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CHAPTER 1 - INTRODUCTION 
 
Porcine parvovirus (PPV) is a small non-enveloped virus considered to be one of the major 
causes of reproductive failure in swine. The clinical signs of PPV infections can be 
characterized by the reoccurring of estrus, abortion and the delivery of mummified or stillborn 
fetuses (MENGELING et al. 2000) and are commonly described with the acronym SMEDI 
(stillbirth, mummification, embryonic death and infertility). The virus is considered to be 
endemic in most areas of the world and can be found in all pig herd categories (TRUYEN 
and STRECK 2012). 
The PPV genome is a single stranded DNA molecule of about 5.2 kilobases. Two large open 
reading frames (ORFs) can be found in the genome, one coding for the non-structural 
proteins (3´ side), and the other coding for the structural virus proteins (5´ side). Sixty copies 
of these structural proteins assemble the icosahedral viral capsid. In each of these copies 
(capsid subunit), a spike on the 3-fold axis, a depression or canyon around the 5-fold axis 
and a dimple on the 2-fold axis can be observed. 
These structural proteins appear to be responsible for the virulence. A sequence comparison 
between the non-virulent NADL2 and the virulent Kresse strains revealed that the non-coding 
regions of these viruses are almost identical. However, in the structural protein genes eight 
differences are present and six of those led to amino acid substitutions. Five of these amino 
acids present in the Kresse strains were also observed in virulent field isolates (I-215-T, D-
378-G, H-383-Q, S-436-P and R-565-K), while three of these substitutions (D-378-G, H-383-
Q and S-436-P) were considered to be responsible for the different tissue tropism 
(BERGERON et al. 1996). 
Despite the several amino acids substitutions observed in the last 10 years (SOARES et al. 
2003; ZIMMERMANN et al. 2006), it has been commonly assumed that PPV has a low rate 
of nucleotide substitution close to that found in its mammalian host (SOARES et al. 2003). It 
was shown that autonomous parvoviruses, including canine parvoviruses and human B19 
erythrovirus, have a nucleotide substitution rate of approximately 1 x 10-4 substitutions per 
site per year, similar to that observed for RNA viruses (SHACKELTON et al. 2005; 
SHACKELTON and HOLMES 2006). 
In this scenario, the continuous use of the same inactivated vaccine in swine herds during 
the last three decades, and the remaining occurrences and reports of reproductive failures 
caused by PPV, highlights the importance of a monitoring of PPV isolates and put in question 
the genome conservative genome of this virus. 
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In addition, by mean of more sensitive molecular techniques, several novel viruses have 
been identified for the first time. In the swine host, porcine parvovirus 2 (PPV2), porcine 
parvovirus 3 (PPV3) and porcine parvovirus 4 (PPV4) were recently identified (HIJISAKA et 
al. 2001; LAU et al. 2008; CHEUNG et al. 2010), but the veterinary importance remain 
unknown. 
In order to address these questions, the present dissertation includes three manuscripts. In 
the first study, recent PPV isolates were analyzed by determining nucleotide substitutions, 
phylogenetic analysis and estimation of the molecular evolutionary rate. In the second, the 
population dynamics of the PPV was performed by using an in vitro and an in silico models. 
In the last manuscript, distribution of novel parvoviruses (PPV2, PPV3 and PPV4) in hearts 
and tonsils of clinically healthy swine from Germany was evaluated. 
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CHAPTER 2 - LITERATURE REVIEW 
Classification and history 
The first report of a parvovirus dates back to the year 1959 (KILHAM and OLIVIER 1959) 
with the description of viruses causing disease in newborn hamsters, called “hamster-
osteolytic viruses”. One of these hamster-osteolytic agents, the Kilham rat virus, was 
identified as the first parvovirus (SIEGL. 1976). In the subsequent years, parvoviruses were 
found in more than five different hosts in several countries (HALLAUER and KRONAUER 
1960; BURGER et al. 1963; BERNHARD et al. 1963; HAMPTON. 1964; CARTWRIGHT and 
HULK 1967; ROSE et al. 1969) and the size, structure and biological properties were defined 
(PAYNE. 1964; KARASAKI. 1966; HOGGAN. 1971; TINSLEY and LONGWORTH 1973). 
Initially, these viruses were classified as picodnaviruses (MAYOR and MELNICK 1966), due 
to their similar size and morphology to the picornaviruses. After the identification of their 
single-stranded properties of the their genome, the name parvovirus was proposed 
(ANDREWS. 1970) and accepted by the International Committee on the Nomenclature of 
Viruses (ICNV). Currently, according to the last release of the taxonomical classification of 
the International Committee on Taxonomy of Viruses (TIJSSEN et al. 2011) the parvoviruses 
comprise the family Parvoviridae, divided in the subfamilies Densovirinae and Parvovirinae. 
The viruses of the subfamily Densovirinae are divided in the genus Brevidensovirus, 
Densovirus, Iteravirus and Pefudensovirus, and infect mostly insects; the viruses of the 
subfamily Parvovirinae consist of the genera Amdovirus, Bocavirus, Dependovirus, 
Erythrovirus and Parvovirus, and infect a wide variety of animals. 
In pigs, the reproductive losses in commercial herds associated to unknown causes were 
high in the 1960s, and, in that time, considered to be associated with environmental, 
nutritional, genetic and toxicological problems (LAWSON. 1961; RASBECH. 1969). The first 
evidence of porcine parvovirus was recognized in primary and secondary cell cultures from 
porcine kidney and testicle used to cultivate hog cholera virus, where persistent contaminant 
small particles (22-23 nm size) were found (MAYR and MAHNEL 1964). These particles 
were found to be similar to the Kilham rat virus (MAHNEL. 1965). Due to the replication 
ability of the virus in cell lines from swine, it was possible to isolate and classified as a 
parvovirus (SIEGL. 1976). 
The occurrence of the PPV in pigs was first described by CARTWRIGHT and HUCK (1967) 
and associated with herd infertility, abortion and stillbirth. In the following years, PPV was 
identified as the main agent for causing the SMEDI syndrome in the pig industry (S: stillbirth, 
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M: mummification, ED: embryonary death and I: infertility) (THOMPSON and PROZESKY 
1994). 
 
Genome 
The genome of parvoviruses is a single stranded DNA molecule of about 4.5 kilobases to 5.5 
kilobases. In both terminal sequences of the virus, a complex palindromic hairpin structure 
(in a similar “Y” or a “T”-shape) of about 120 to 200 bases is located (BERNS and 
HAUSWIRTH 1983). These structures can serve as primers during the viral DNA replication 
and probably play an important role for the viruses’ genome integrity. Two large open reading 
frames (ORFs) are present in the parvovirus genome, one coding for the non-structural 
proteins, and the other coding for the structural virus proteins (Figure 1). For PPV, the ORF 
located at the 5´end of the genome encodes the non-structural protein 1 (NS1), and by 
means of alternative splicing also encodes the NS2 and NS3 non-structural proteins 2 and 3 
(NS2 and NS3) (BERGERON et al. 1996). The NS1 protein has a helicase and nickase 
function, being responsible for viral replication and packaging. In contrast, the exact functions 
of NS2 and NS3 proteins are still unknown (NUESCH et al. 1995). At the 3´end, one small 
ORF and the large ORF encodes for the viral protein 1 (VP1) by using a splicing, the viral 
protein 2 (VP2) is transcribed from the same ORF and the viral protein 3 is an enzymatic 
cleavage product of the VP2 (BERGUERON et al. 1996). Additionally, an accessory protein 
for replication (SAT) is codified by another small ORF located in the middle of the genome, 
close to the VP2 start codon (ZADORI et al. 2005). The entire genome transcription is guided 
by only two promoters: P4, located at the 5´ extremity of the genome, initiates the 
transcription of the non-structural proteins; and the P40, located at the middle of the genome, 
initiates the transcription of the viral proteins and SAT protein (BERGERON et al. 1996). 
 
Figure 1. Coding map of the PPV genome. Blue arrow indicates mRNA precursor and red 
arrows indicate gene products. Nucleotide numbers are indicated above. The graphic was 
generated on the NCBI homepage (http://www.ncbi.nlm.nih.gov/) using the NADL2 strain 
(GenBank accession number NC_001718). 
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Structural characteristics 
The capsid of PPV is a spherical shell consisting of 60 identical copies of the viral proteins 
arranged in an icosahedral symmetry (Figure 2) (CHAPMAN and ROSMANN 1993). Each of 
the 60 copies is built by the amino acids located between site 37 and 584 of the VP2 protein 
and is called “capsid subunit” (TSAO et al. 1992). The subunit consists of eight antiparallel β-
strands, a common structure for viral capsids, together with one &-helice and four loops 
(Figure 2) (CHAPMAN and ROSMANN 1993). On the surface, a projection at the 3-fold axis, 
a depression or canyon around the 5-fold axis and a dimple on the 2-fold axis of symmetry 
can be observed. The 2- and 3-fold axes consist mainly of amino acids located in the subunit 
loops. These regions are considered to be important for the viral infection and 
immunogenicity (SIMPSON et al. 2002). 
On the internal surface of the PPV capsid several neutral amino acids are located. This is 
unusual for viruses, which usually harbor basic amino acids on their internal virus surface, 
which are supposed to interact with the DNA molecule phosphates (XIE and CHAPMAN 
1996). As hypothesis, the presence of several basic residues (in the neutral amino acids) 
among the parvoviruses binding sites could result in a high electrostatic enthalpy reaction 
with the DNA molecules (STEITZ et al. 1990) ensuring, this way, an efficient packaging of 
the viral genome. 
 
         
A      B 
Figure 2. The capsid structure of the PPV. A: Surface representations of the capsid 
calculated from X-ray coordinates with a low pass filter at 17 Å in a temperature factor of 500 
Å. B: 3D model of the PPV VP2 proteins using the cartoon technique, with a rocket (&-helice) 
and arrows (β-strands) representing the secondary structure. The image was generated with 
CHAPTER 2 - LITERATURE REVIEW 
6 
 
the software Cn3D version 4.1. The coordinates of both figures were retrieved from the NCBI 
Structure Database (http://www.ncbi.nlm.nih.gov/Structure/index.shtml). Accession number: 
1K3V (SIMPSON et al. 2002). The neighboring five- (in blue), three- (in red) and twofold (in 
green) axes of the capsid subunit are shown. 
 
Epidemiology 
Porcine parvovirus is considered to be endemic in most areas of the world. The virus can be 
found in all pig herd categories, including in boars and fattening pigs. In the first studies 
about the topic, it was observed that PPV had a high infection level in pigs, with a sero-
conversion rate of 30% to 90% among animals tested (BACHMAN. 1969; JONHSON and 
COLLINGS 1969; MENGELING. 1972). This lead to the development and common use of 
inactivated vaccines since the 1980s (TRUYEN and STRECK 2012). It is not unusual to find 
vaccinated sows with high antibody titers ( > 1:512), indicative of viral activity, and even 
outbreaks in regularly vaccinated animals (DIAS et al. 2012). Furthermore, PPV DNA can 
also be demonstrated in those animals and their appear independent of the observed the 
antibody titers (STRECK et al. 2011). 
The epidemiology of porcine parvovirus is primarily marked by the high stability of the virus in 
the environment. PPV can remain infectious for months, and contaminated instruments or 
stables may therefore be a constant source of infection. The virus can be transported by the 
clothing of farmers from one herd to another, and it is also speculated that rodents can 
mechanically introduce the virus into new herds (TRUYEN and STRECK 2012). 
The virus spreads in a herd usually through feces and other secretions from acutely infected 
pigs. The introduction of the virus does not necessarily cause clinical problems. If sows are 
regularly vaccinated or naturally immunized, the viruses’ infections may be asymptomatic 
(TRUYEN and STRECK 2012). Separation or acquisition of gilts for breeding could result in 
the selection of naïve animals and when these gilts are introduced into an infected herd, it 
may lead to acute outbreaks of infection (SZELEI et al. 2006). 
The virus can also be introduced into susceptible herds by infected boars. Seronegative 
boars could become infected by the oronasal route or during coitus, if virus is in the vaginal 
mucus (SZELEI et al. 2006). According to several reports, PPV was already observed in 
semen of naturally infected boars (CARTWRIGHT and HULK 1967; CARTWRIGHT et al. 
1969; RUCKERBAUER et al. 1978); however, it is controversially discussed whether the 
virus could reach the testis during infection, or if the positive results represent secondary 
contaminations. 
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Pathogenesis 
The primary replication of the PPV is suggested to occur in lymphoid tissues. After that, the 
virus is distributed systemically via viremia (PAUL et al. 1980). In the porcine epitheliochorial 
placenta, six tissue layers completely separate the sow and the fetal blood circulation. Since 
these cells are closely connected, not allowing the passage of even small molecules as 
antibodies, it is still not understood how the PPV crosses this placental barrier and reaches 
the fetus (MENGELING. 2000). Probably, as the virus was already detected in lymphoid 
tissue from pigs (LUCAS et al. 1974), in fetal lymphocytes (RUDEK and KWIATKOWSKA 
1983) and is able to remain infectious after phagocytosis by macrophages (PAUL et al. 
1979), PPV could use them to infect the fetus. After fetal infection, the PPV has an 
environment particularly susceptible to infection and to replication due to the high mitotic 
activities present in the fetuses’ tissues (TRUYEN and STRECK 2012). 
Parvoviruses use a variety of glycoproteins, glycans and glycolipids to attach to cells 
(HARBINSON et al. 2008). The entry mechanisms of PPV are still unclear, but seem to 
include clathrin-mediated endocytosis, or macropinocytosis, followed by transportation 
through the endosomal pathway (BOISVERT et al. 2010). The consequent endosome 
acidification results in reversible modifications in the virus’ capsid, which may allow the viral 
escape from the endosome (VIHINEN-RANTA et al. 2002; FARR et al. 2005). Probably, 
acidification can externalize the phospholipase A2 motif (PLA2) from the capsid, which is 
supposed to be essential to break the vesicular membranes (GIROD et al. 2002), and to 
enter the cellular nucleus (VENDEVILLE et al. 2009). Once in the nucleus, the parvoviruses’ 
replication is conducted by the cell DNA polymerase complex. 
The virulence properties of the PPV appear to be related to the viral protein gene. A genetic 
comparison between the non-virulent NADL2 and the virulent Kresse strains revealed that 
the non-coding regions of these viruses are nearly identical. For the non-structural gene 
region (NS1/NS2), all differences found are silent (synonymous), while in the structural 
genes (VP1/VP2) six of eight differences led amino acid substitutions (non-synonymous). 
Five of these different amino acids present in the Kresse strains were also observed in 
virulent field isolates (I-215-T, D-378-G, H-383-Q, S-436-P and R-565-K), and three of these 
amino acid substitutions (D-378-G, H-383-Q and S-436-P) were considered to be 
responsible for the different tissue tropism (BERGERON et al. 1996). In the capsid subunit, 
the amino acid positions 378, 383 and 565 are located next to the 2-fold axe and these 
locations have been suggested to be important for immune response and hemagglutination 
activity (BERGERON et al. 1996). The amino acid position 436 is located right in the 3-fold 
spike center of the capsid subunit and the amino acid position 215 at its base. This location 
in the 3-fold spike has been considered to be an important antigenic surface region in various 
parvoviruses (CHAPMAN and ROSSMANN 1993). 
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Clinical signs 
The major clinical sign of PPV infections are reproductive failures in sows (Figure 3). Even 
after experimental inoculation, other clinical signs in boars and gilts could not be 
demonstrated (MENGELING and CUTLIP 1976; THACKER et al. 1987). Subclinically, a 
moderate and transient lymphopenia, independent of sex and age, can be observed between 
5 and 10 days after initial infection (JOO et al. 1976b; MENGELING and CUTLIP 1976; 
ZEEUW et al. 2007). Reports identifying PPV in the feces of pigs with diarrhea were 
published as well. However, whether the virus replicates in the intestinal epithelium and 
thereby causes enteric diseases, as observed in parvovirus infections in other animals, is 
uncertain (DEA et al. 1985; YASAHURA et al. 1989). Additionally, PPV was also isolated in 
vesicular lesions, but without defined etiological role (KRESSE et al. 1985). 
 
 
Figure 3. Litters of inoculated pregnant sows (with 27a and NADL2 viruses) at the 90th 
gestation day displaying distinct levels of lesions. The fetuses’ position correspond to their 
position in the uterus (the most cervical-positioned fetuses at the top) (ZEEUW et al. 2007). 
 
CHAPTER 2 - LITERATURE REVIEW 
9 
 
For the female, the pathological sequela caused by PPV is related mainly to the gestational 
period in which infection occurs (Figure 4). At the gestational beginning, the conceptus is 
protected by the zona pellucida and is therefore resistant to infection. During the stage of the 
embryo, infection with PPV results in embryonic death and resorption. From the 35th day on, 
i.e. the beginning of the ossification, the infection results in death and subsequent 
mummification. Finally, around the 70th day from gestation, the fetus is already immune 
competent and may resist viral infection. An infection in this stage is then usually controlled 
and the piglet is born with anti PPV antibodies (JOO et al. 1976a; LENGHAUS et al. 1978). 
 
 
Figure 4. Clinical consequences of PPV infection observed in various time-points of 
gestation. Adapted from MENGELING et al. (2000). 
 
Diagnosis 
A possible PPV infection should be investigated always when one of the following signs can 
be identified: increasing of the return-to-estrus index; abortions associated with mummified 
fetuses; failure to farrow; stillbirth; weak piglets and small litters. These symptoms mainly 
occur in first or second parity order females and are usually not followed by other clinical 
manifestations (SZELEI et al. 2006; TRUYEN and STRECK 2012). As differential diagnosis, 
reproductive diseases like Aujeszky’s disease, brucellosis, leptospirosis, porcine 
reproductive and respiratory syndrome (PRRS), toxoplasmosis and unspecific bacterial 
uterine infections should be excluded. 
The material submitted to laboratory for direct diagnosis should include frozen mummified 
fetuses and fetal remains. Traditionally, the virus detection and titration can be performed by 
the hemagglutination technique (HA), based on the hemagglutinating activity of PPV against 
erythrocytes of certain species, e.g.: chickens, humans, guinea pigs (JOO et al. 1976b). 
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Since the virus has a high replication efficiency in renal or testicular swine cells, virus 
propagation in cell-lines such as ESK (embryonic swine kidney), PK-15 (pig kidney), SK6 
(swine kidney), STE (swine testicular epitheloid) and SPEV (swine embrio kidney) is 
routinelly used. Once in these cells, the PPV replication usually causes cytopathic effects, 
including granulations, irregular shape, slow replication, intra-nuclear inclusions, pyknotic 
nucleus and consequently cell death (CARTWRIGHT et al. 1969; MENGELING. 1972). Due 
to possible similar cytophatic effects of other viruses or enzymatic effects, virus isolation is 
often associated with immunofluorescence microscopy (Figure 5) (CARTWRIGHT et al. 
1971; JONHSON. 1973; MENGELING et al. 1978). 
 
 
Figure 5. Indirect immunofluorescence of PK-15 cells infected with PPV. Positive nuclear 
fluorescence (green) is evidenced five days post-infection. Magnification of 400x. 
 
More recently, nucleic acid-based techniques can be used for viral detection in clinical 
samples with a better sensitivity. The PCR, a useful technique in fetal tissues, possesses 
higher sensibility and even specificity than the HA (SOARES et al. 1999). Additionally, 
several real-time PCR protocols have been described, using Taqman probes (CHEN et al. 
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2009) or SYBR Green (MIAO et al. 2009; WILHELM et al. 2006) which can be used for viral 
DNA detection and quantification. 
Alternatively, serum from gilts and sows can be tested at the time of reproductive failure, with 
a second sampling performed 2-4 weeks later. As standard method, the hemagglutination 
inhibition (HI) assay is frequently used for the quantification of PPV specific antibodies. 
Usually, the serum examined by HI test needs to be pre-treated by heat inactivation followed 
by adsorption with kaolin (MORIMOTO et al. 1972). Another technique, the enzyme-linked 
immunosorbent assay (ELISA) can be standardized more easily and is suited to 
automatization. Moreover, serum does not have to be pre-treated before testing in the ELISA 
(HOHDATSU et al. 1988; WESTENBRINK et al. 1989). The ELISA can potentially 
differentiate vaccinated animals from animals having been infected with PPV. As the 
currently used inactivated vaccines induce antibodies only against PPV VP proteins and not 
against the NS proteins, ELISAs that differentiate these two proteins could identify an field 
virus infection (MADSEN et al. 1997; QING et al. 2006). 
 
Immunity 
The first protection of the piglet against PPV takes place via colostral antibodies consumed in 
the first day of life. The piglet itself starts to produce antibodies in the second week of live; 
meanwhile the maternal antibody titer decreases gradually, with antibodies being still 
detectable until 4-6 months of live (JONHSON et al. 1976). If the animal is vaccinated in the 
presence of a high maternal antibody titer, these antibodies can interfere with vaccination. 
On the other hand, if the antibody levels decrease swiftly the animal will be unprotected for 
several weeks until vaccination. Therefore, the time point of the first vaccination is important 
for a successful vaccination program. 
The antibody titers raised by commercial vaccines and those raised by natural infections are 
markedly different. By HI test, the vaccine antibody titers are commonly lower than 1:512 
(ORAVAINEN et al. 2005), whereas the antibody titers after a field infection can regularly 
exceed 1:2000 (van LEENGOED et al. 1983). Usually, the animal produces titers 6-9 days 
after vaccination/infection, with the peak between day 14 and 21 (JONHSON and COLLING 
1969; CARTWRIGHT et al. 1971). The titers can remain high in sows for about four years 
after a natural infection (JONHSON et al. 1976). However, it is also suggested that a latent 
PPV infection is able to cause persistence of detectable antibodies (SZELEI et al. 2006). 
The use of the inactive vaccine against PPV reduced the reproductive problems associated 
with PPV in herds. As inactive vaccines are expected to produce mainly humoral response, it 
is usually agreed that the protection against the PPV is mediated mainly through protective 
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antibodies. Cellular immunity is also described, mainly based on cytotoxic T lymphocytes 
(CTL). In experimental infections with naïve animals, the CTL response was weak in animals 
that received only one viral inoculation. This is suggested as a result of the rapid response of 
the humoral immunity, clearing the infection before CTL activation. However, CTL response 
was markedly evident in a second infection, indicating that CTLs may play a role in 
controlling PPV re-infections (LADERKJÆR-MIKKELSEN and NIELSEN 2002). 
 
Prevention and control 
Currently, there is no specific treatment against PPV. Additionally, the widespread and 
resistant characteristics of this virus lead to difficulties to control the virus. Practices that 
ensure the biosafety and herd´s hygiene are of major importance to reduce contamination. 
However, the most efficient measure is the regular vaccination of the breeding stock 
(TRUYEN and STRECK 2012).  
Before the worldwide dissemination of the commercial vaccine, the “feed-back” technique 
was usually used in herds. This technique was based on an induced infection of the gilts 
approximately one month before the insemination. The immunization was performed through 
direct contact of the sows with feces and abortions´ remains (TRUYEN and STRECK 2012). 
The technique provided immunization with a high antibody titer, but as viruses were not 
eliminated or reduced, a potential risk of infection outbreaks was always present. 
The first vaccines were experimentally developed in the end of the 1970s (JOO and 
JOHNSON 1977; MENGELING et al. 1979). A few years later, regular vaccination of 
breeding sows with inactivated vaccines became a worldwide practice. Currently, PPV 
vaccines are a cell culture derived virus (usually the non-pathogenic NADL2 strain) which is 
chemically inactivated (by formalin, beta-propiolactone or binary ethyleneimine), mixed with 
oil or aluminium hydroxid as adjuvants and administrated parenterally (TRUYEN and 
STRECK 2012). The use of these vaccines induces antibody titers that can reduce clinical 
manifestations, but cannot prevent infection (JÓZWIK et al. 2009). The vaccination 
schedules can be adjusted to the animal category. Gilts receive the first dose at the age of 
170-180 days, or 30 days before insemination. The second dose is usually administrated 15 
days later. Sows are boosted usually 10-15 days after each farrowing. Boars can be 
vaccinated as well and boosted yearly. 
Modified-live virus vaccines (MLV) could be an alternative for PPV. Reports on PPV MLVs 
were made in the 1980s using the NADL2 virus (PAUL and MENGELING 1984). In all cases 
transplacental transmission was prevented, but viremia and shedding of the vaccine strain 
after vaccination was observed. More recently, an experimental infection of pregnant sows 
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with the strains 143a, IDT, NADL2 and Stendal (strains considered to have low virulence) 
also revealed no transmission of these viruses to the fetuses. Additionally, these strains 
induced a very strong humoral immune response (ZEEUW et al. 2007).  
 
The emergence of novel phenotypes 
Genetic variability of PPV and the emergence of new phenotypes are a very recent topic. 
The first study focusing on genetic variability of PPV field strains was published in 2002, with 
strains isolated in Brazil from 1994 to 2000 (SOARES et al. 2003). In this study, a partial 
fragment of the VP2 gene was analyzed and at least eighteen different phenotypes (differing 
at least in one amino acid) were identified and disposed in two phylogenetic groups. 
Additionally, a similar study analyzing samples from Germany, isolated in 2001 and 2002, 
observed six different phenotypes which could be phylogenetically distinguished in two 
clusters (ZIMMERMANN et al. 2006). Thereafter, studies with field samples from China and 
Romania were published describing several new phenotypes as well (SHANGJIN et al. 2009; 
HAO et al. 2011; CADAR et al. 2012). 
The report of these several PPV phenotypes raises questions about the conservative 
properties of the PPV genome. Currently, it is not clear whether these new PPV phenotypes 
represent a viral emergence or only viruses that are now detectable due to more sensitive 
techniques. Furthermore, it was observed that new phenotypes with amino acid substitutions 
in the capsid protein have modified their antigenic properties, and differences in the cross 
neutralization of sera raised against NADL2 and IDT viruses (used in the commercial 
vaccines) have been demonstrated. Those findings lead to the hypothesis that the 
emergence of new mutations could be a viral adaptation to the largely used vaccines 
resulting in “escape mutants” (ZEEUW et al. 2007). 
 
The emergence of novel parvoviruses 
In the last decade, with the development of novel molecular techniques, like the next 
generation sequencing, several viruses have been identified for the first time. For porcine 
parvoviruses, the virus H-1 in sera from pigs in Myanmar was the first newly identified virus 
(HIJISAKA et al. 2001), originally termed as porcine parvovirus 2 (PPV2). The virus was 
accidentally PCR amplified during an attempt to identify hepatitis E virus. Recently, in the 
USA, a high prevalence of this virus was found in lung samples (20.7%) and a moderate 
prevalence in feces (7.6%). Also in thoracic fluids the virus could be detected (1.6%).  
In 2008, a virus closely related to the human parvovirus 4 was found in slaughtered pigs in 
Hong Kong (LAU et al. 2008). Currently, several sequences with high homology (> 98 % 
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DNA similarity) exist in the DNA databanks under different names, including porcine 
hokovirus, PARV4-like and porcine parvovirus 4. The virus has already been detected in 
several countries (CADAR et al 2011; PAN et al. 2012; XIAO et al. 2012), including 
Germany, where a high DNA detection rate (37.7%) was observed in hunted wild boars 
(ADLHOCH et al. 2010). 
In 2010, another parvovirus was found in lungs from a diseased pig co-infected with porcine 
circovirus type 2 and designated as porcine parvovirus 4 (PPV4) (CHEUNG et al. 2010). 
After that, the virus was found in diseased animals in China (HUANG et al. 2011). Finally, in 
pigs with postweaning multisystemic wasting syndrome (PMWS), a porcine bocavirus (PBoV) 
was identified in lymph nodes (BLOMSTRÖM et al. 2009). No correlation with clinical signs 
could be observed, which is also true for the other novel parvoviruses as well. 
Probably, the novel parvoviruses may have a limited clinical implication on swine health; 
however, they may possess a potential public health interest due to their genetic similarity 
with human parvoviruses.
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ABSTRACT 
In the last years, it has been shown that some parvoviruses exhibit high substitution 
rates, close to those of RNA viruses. In order to monitor and determine new mutations 
of the porcine parvovirus (PPV), recent PPV field isolates from Austria, Brazil, 
Germany and Switzerland were sequenced and analyzed. These samples, together 
with sequences retrieved from GenBank, were included in three datasets (consisting of 
a VP1 complete gene, VP1 partial gene and NS1 complete gene). For each dataset, 
the nucleotide substitution rate and the molecular clock were determined. The analysis 
of the PPV field isolates revealed that a recently described amino acid substitution, S-
436-T, appears to be common in the VP2 protein in the Austrian, Brazilian and German 
virus population. Furthermore, new amino acid substitutions were identified, being 
mainly located in the viral capsid loops. By inferring the evolutionary dynamics of the 
PPV sequences, nucleotide substitution rates of approximately 10-5 nucleotide 
substitutions per site per year for the non-structural protein gene and 10-4 for the capsid 
protein gene (for both viral protein datasets) were found. The latter rate is similar to that 
commonly found in RNA viruses. An association of the phylogenetic tree with the 
molecular clock analysis revealed, that the mutations, on which the divergence for both 
capsid proteins is based, occurred in the last 30 years. Based upon these findings, one 
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can conclude that PPV variants are continuously evolving and that vaccines, which are 
mainly based on strains isolated about thirty years ago, should possibly be updated. 
 
INTRODUCTION 
The porcine parvovirus (PPV) was first isolated in Germany and in the United States in 
1965 and later found worldwide (CARTWRIGHT and HUCK 1967; JOHNSON. 1973; 
JOO et al. 1976; SIEGL. 1976). PPV is considered to be a major cause of reproductive 
failure in swine. Clinical signs of PPV infections are characterized by the reoccurring of 
estrus, abortion and the delivery of mummified and stillborn fetuses (MENGELING et 
al. 2000) commonly described with the acronym SMEDI (stillbirth, mummification, 
embryonic death and infertility). 
PPV is a small, single-stranded (ss) DNA virus. The genome has a length of about 
5000 nucleotides encoding four proteins transcribed from two promoters and the 
coding capacity is extended through alternative splicing. Two nonstructural proteins, 
NS1 and NS2, are transcribed and translated from the 5´ ORF and are important for 
DNA replication. Additionally, two structural proteins are transcribed and translated 
from the 3´ ORF (VP1 and VP2). The smaller protein, VP2, is produced by splicing 
from the same RNA template as the larger protein (VP1). The whole VP2 sequence is 
therefore present in the VP1, which has a unique amino terminus of about 120 amino 
acids. A third protein, VP3, is a post-translational modification product of VP2 (Simpson 
et al., 2002). Together, these three viral proteins assemble to form the icosaedral 
capsid (CHAPMAN and ROSSMANN 1993; PARRISH 2010). Various biotypes of PPV 
with different pathogenic properties are known. The genetic basis of the pathogenicity 
has not yet been defined, but the structural protein appears to play a major role. A 
genomic comparison between the non-pathogenic strain NADL2 (GenBank accession 
number L23427) and the virulent strain Kresse (U44978) revealed that the non-coding 
regions of the genome are nearly identical (BERGERON et al. 1996). All nucleotide 
substitutions found in the NS genes are silent, while six out of eight substitutions 
located in the structural genes (VP1/VP2) change the transcribed amino acid. In detail, 
among the VP2 amino acids, five changes are consistent in comparison with the field 
isolates (I-215-T, D-378-G, H-383-Q, S-436-P and R-565-K) and three of these amino 
acid changes (D-378-G, H-383-Q and S-436-P) are considered to be responsible for 
the different tissue tropism (BERGERON et al. 1996). Recently, genetic variation and 
the possible emergence of a new antigenic type of PPV has been described 
(ZIMMERMANN et al. 2006), although its importance in the field is still unclear. 
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As PPV replicates by using the host DNA replication machinery, it is generally 
assumed that the virus has a low rate of nucleotide substitution close to that found in its 
mammalian host. In the last years, it was shown that canine parvoviruses and human 
B19 erythrovirus, both autonomous parvoviruses, have a nucleotide substitution rate of 
approximately 1 x 10-4 substitutions per site per year (SHACKELTON et al. 2005; 
SHACKELTON and HOLMES 2006). This rate is similar to that known for RNA viruses. 
The continuous use of an inactivated vaccine in swine herds in the last three decades, 
and the remaining occurrences and reports of reproductive failures caused by PPV, 
highlights the importance of a continuous monitoring of PPV isolates. To address these 
questions, recent PPV isolates were analyzed by determining nucleotide substitutions, 
phylogenetic analysis and the estimation of the molecular evolutionary rate of PPV. 
 
RESULTS  
GENETIC ANALYSIS OF THE NEWLY IDENTIFIED SEQUENCES 
In order to identify new mutations, recent isolates from Austrian, Brazil, Germany and 
Switzerland were analyzed. The sequence analysis of the structural gene (VP2) of 
these isolates (n=9) revealed nucleotide substitutions at 32 sites. Seventeen 
substitutions were synonymous and fifteen substitutions were non-synonymous. In the 
region previously considered as highly variable [located between the nucleotides 3889 
to 4239 of the full PPV genome (ZIMMERMANN et al. 2006)], three synonymous 
substitutions and five non-synonymous substitutions were found. Two conserved 
regions (with no nucleotide substitution) could be defined between the nucleotides 
3507-3718 and 4251-4425. 
The analysis of the nonstructural genes (NS1) of the new isolates (n=9) revealed 
nucleotide substitutions in 44 sites. Twenty-seven substitutions were synonymous and 
seventeen substitutions were non-synonymous. Conserved regions (with no nucleotide 
substitution) were identified in sites 568-781, 847-1022, 1072-1362 and 1504-1793. 
At the protein level, conserved regions are located in the structural gene between 
amino acids 83-225 and 437-579. Two variable regions were found: 226-233 and 365-
436. For the nonstructural gene, conserved regions (with no amino acids substitution) 
were located between the amino acids 83-163, 165-357 and 368-561. A region with a 
higher variability was observed at the end of the gene, between the amino acids 562-
658. 
CHAPTER 3 - HIGH EVOLUTION RATE IN THE PPV CAPSID PROTEIN 
18 
 
The amino acid substitutions in the structural gene per isolate displayed per isolate in 
Table 1. In the sites that differ between the NADL2 and the Kresse strain, the recent 
isolates appear to be nearly homologous to the Kresse sequence. Unique amino acids 
substitutions could be identified in the sites 436 and 565. In all the new German and 
Austrian strains, substitutions were located in sites 228, 414 and 419. In the site 436, 
all German strains contained the amino acid Threonine, which was also observed in 
the Brazilian strain S30. A higher number of amino acid substitutions, in comparison to 
the other isolates, could be shown in strain 15425 with six unique amino acids 
changes. 
 
Table 1. Amino acid substitution within PPV VP2 sequences. 
  
VP isolate 
 
Am
in
o
 
a
cid
 
VP
2 
Kr
e
ss
e 
NA
DL
2 
27
a
 
15
42
5 
7a
 
8a
 
14
a
 
69
3a
 
Em
br
a
pa
 
PA
 
PB
 
S3
0 
20 T T T A T T T T ND ND ND ND 
45 S T S S S S S S ND ND ND ND 
82 R R R K R R R R ND ND ND ND 
215 T I T T T T T T ND ND ND ND 
226 Q Q Q E Q Q Q Q ND ND ND ND 
228 Q Q E Q E E E E ND ND ND ND 
233 S S T S S S S S ND ND ND ND 
304 P P P T P P P P ND ND ND ND 
320 I I I T I I I I I I I I 
366 D D D N D D D D D D D D 
378* G D G G G G G G D D D G 
383* Q H Q Q Q Q Q Q H H H Q 
407 K K K N K K K K K K K K 
414 A A S A S S S S A A A A 
419 E E Q E Q Q Q Q E E E E 
423 N N N N N N N N N K N N 
436* P S T P T T T T S S S T 
565 K R K K K K K K R R R K 
 
*Site considered responsible for the different tissue tropism (BERGERON et al. 1996). 
ND: not determined 
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SUBSTITUTION RATES AND SELECTION PRESSURES 
Only the MaxChi method (from the five method tested) estimated a recombination 
event in the samples 7a (this study), 143a (AY684867) and 32260005_1d (GQ884037) 
in the NS1 dataset. Since no consensus was obtained with three or more methods, all 
samples were used for further analysis. 
The root-to-tip analysis was constructed to examine whether the samples exhibited 
adequate temporal structure for a substitution rate analysis. The first plot of the genetic 
distance versus the isolation year of the sample displayed an outlier sequence [IDT 
(AY684872)]. This sequence was excluded from the further analysis [according to the 
methodology adopted by SHACKELTON and HOLMES (2006)] and a new ML tree and 
root-to-tip plot was calculated (Figure 6). The R-squared obtained by the linear 
regression for the VP1 complete gene, VP1 partial gene and NS1 complete gene were 
0.3828, 0.4438 and 0.2984, respectively. 
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Figure 6. Linear regression plot graphic between the genetic distances (number of 
substitution per site) versus the isolation year for each sample in the distinct datasets. 
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The mean evolutionary rate estimated for the three data sets, using the BEAST 
approach, ranged from 10-5 to 10-4. According to the model best fitting the data, the 
dataset of the nonstructural genes, VP1 complete gene and the VP1 partial gene 
presented a mean rates (substitution/site/year) of 5.39 x 10-5, 3.02 x 10-4 and 4.04 x 10-
4
 (respectively) (Table 2). According to the methodology, a mean variation of between 
4.00 - 7.73 x 105 for the nonstructural dataset, a mean variations of between 1.74 - 
3.02 x 104 for the VP1 complete dataset and a mean variation of between 3.93 - 4.45 x 
104 for the VP1 partial datasets were obtained. 
 
Table 2. Sequence information, clock model, demographic model, marginal Likelihood 
(ml), mean of nucleotide substitution rate (mean rate in subs/site/year) and the 
corresponding 95% Higher Posterior Density (HPD) lower and upper for the three data 
sets. 
Data set Sequences 
length (nt) 
Sequences 
number 
Clock 
model 
Dem. model ml Mean rate HPD 
VP1 complete 2187 31 UCED  Constant -4022.3 3.02 x 10-4 4.86 x 10-4, 1.43 x 10-4 
VP1 partial 739 65 UCED  BS  -1762.7 4.04 x 10-4 5.72 x 10-4, 2.56 x 10-4 
NS1 complete 1989 31 UCED  BS  -3867.2 5.39 x 10-5 1.97x 10-7, 1.37 x 10-4 
 
The difference between non-synonymous and synonymous substitution rates (dN/dS) 
for the NS1 and VP1 datasets presented variable results according to the methodology. 
A chi-square test comparison between the models M7 and M8 revealed that both 
complete genes are under purifying selection [NS (p = 0.3146) and VP (p = 0.0407)]. 
Furthermore, no positive selection sites were found in the M8 model. On the other 
hand, evidence of a positive selection for the VP partial dataset was found with the M7 
and M8 models (p = 0.0006) and in the MEGA analysis (dN/dS = 1.610). For the VP1 
(complete and partial), no evidence could be identified in the branch-site model test (p 
= 0.0786 and 0.9972, respectively) for the case that different selective pressures would 
drive the evolution of the distinct lineages/branches. In contrast, branches 
characterized by different selective pressures were present within the NS1 dataset (p = 
0.0001). 
 
PHYLOGENETIC ANALYSIS 
As shown in Figure 7, the Bayesian maximum clade credibility tree generated for the 
VP1 complete gene revealed two different clades [here called A and B (posterior 
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probability < 0.90)] and two clusters [C and D (posterior probability = 1.0)]. The new 
German and Austrian strains were located in Cluster C, and the Swiss strain was 
located in Cluster D.  
In the tree that is based upon the partial VP1 gene sequence, clades and clusters A-D 
were also present and additionally, two other clades [E and G (posterior probability < 
0.90)] and one other cluster [F (posterior probability = 1.0)] could be identified. The new 
German and Austrian strains remained in the same cluster, while the new Brazilian and 
the Swiss strains were located in Clade B and cluster D, respectively. On the contrary, 
except for ZJ (EU790642) [with no clade (VP partial) ↔ clade B (VP complete)] and 
225b (AY684864) [cluster C (VP partial) ↔ cluster D (VP complete)] all the sequences 
were affiliated with the same clade/cluster in the VP1 complete and the VP1 partial 
tree. In the NS gene tree, almost all sequences formed distinct clusterizations and the 
only clusters in agreement with the VP1 trees were D and F. 
The chronological analysis of the NS and VP1 datasets demonstrated two distinct 
temporal periods. In the structural genes, the main divergences occurred in the last 30 
years for both datasets, and the events resulting in the outcome of new strains were 
dated back to the last 20 years. In the nonstructural dataset, the divergences were 
estimated to be formed in the former time period of between 10 to 125 years ago, being 
mainly concentrated in the last 30-60 years. 
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Figure 7. Phylogenetic tree based on BI analysis of PPV for the three datasets. The 
scale axis indicates the distance in years. Posterior probabilities (≥0.90) are indicated 
above the branches. The name (identification) of each sequence is followed by the 
location and year of isolation. The location is coded as: AUS (Austrian), BR (Brazil), CH 
(China), EU [Europe (no precise location available)], GE (Germany), SW (Switzerland), 
UK (United Kingdom) and USA (United States). For both VP trees, clades/clusters are 
delimitated and indicated with the letters A-G (continue line = cluster; discontinue line = 
clade). 
 
DISCUSSION 
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A possible antigenic selection of PPV mutations, as a consequence of the current 
vaccination schedules, have been discussed in the past years (SOARES et al. 2003; 
ZEEUW et al. 2007; ZIMMERMANN et al. 2006). In the present paper, new virus 
sequences from Austria, Brazil, Germany and Switzerland, together with the available 
PPV sequences from GenBank/Embl/DDBJ, were analyzed and the evolutionary rate 
of this virus was calculated. 
The analysis was performed using three different datasets. The VP1 partial dataset 
represents a small region of the VP1 gene; however, it enabled us to analyze a higher 
number of sequences over a broad range of years. The phylogenetic trees generated 
for the VP1 complete and partial genome contained four (A-D) and seven 
clades/clusters (A-G), respectively, and the majority of the sequences located in the A-
D Clades/Clusters matched in both datasets (Figure 7). This suggests that the 
analyses of this short region of the VP1 gene (e.g.: SOARES et al. 2003) can be used 
as a representation of the full-length gene. 
In a previous study that analyzed the complete VP1 gene, the authors discussed that 
the recent German strains 15a (AY684865), 21a (AY684868) and 27a (AY684871) 
formed a new phylogenetic cluster (ZIMMERMANN et al. 2006). The new German and 
Austrian strains were located in this cluster (Cluster C) present in both VP trees 
(complete and partial gene), and together with European sequences isolated in 2005-
2006. The Swiss strain was located in Cluster D together with German and other 
European strains. Both of the clusters containing mainly German sequences and a 
cluster with Chinese sequences were characterized by high phylogenetic confidence, 
indicating that these clusters could have emerged from a well established ancestor. 
The Brazilian strain S30 was located in the Clade B together with two United States 
strains and one European strain. One other cluster (F) and two other clades (E and G) 
were seen in the partial dataset phylogeny. Cluster F was formed by Chinese strains, 
and Clades E and G only clustered in Brazilian strains. The two clades mainly formed 
by Brazilian strains have already been described in a previous study, where Maximum-
parsimony analysis was carried out on a similar dataset (SOARES et al. 2003). 
A comparison of both VP1 datasets with the NS1 dataset on the phylogenetic level was 
difficult. Only two VP clusters could be observed (D and F) in the tree generated for the 
NS1 gene. According to our temporal analyses, two distinct evolutionary rates between 
these genes were found. The phylogenetic incongruencies between both genes could 
reflect the different evolutionary development of these genes. 
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At the protein level, amino acids differing in the VP2 protein, when regarding the 
NADL2 and Kresse strains, were equally distributed between loops and β-strands. 
Here, we observed that the substitutions in the new strains were mainly located in the 
protein loops (Figure 8). The only exception was the amino acid 82 (R → K) 
substitution at the site number 82 in the Swiss strain 15425. Several substitutions in 
these loops could also be observed in the canine parvovirus and are reported to be 
involved in cell specificity and hemagglutination activity (CHAPMAN and ROSSMANN 
1993). The substitutions 226 (Q → E), 228 (Q → E), 320 (I → T), 419 (E → Q) and 423 
(N → K) were located near the 3-fold shoulder of the capsid subunit. This location has 
been considered to be a common antigenic surface region in distinct parvoviruses 
(CHAPMAN and ROSSMANN 1993). These sites are also further displaced from the 
center of the PPV capsid in comparison with other capsid protein amino acids 
(SIMPSON et al. 2002), suggesting that these sites may interact with the host immune 
system. 
 
 
Figure 8. A 3D model of the PPV VP2 proteins using the cartoon technique, with 
rockets (&-helices) and arrows (β-strands) representing the secondary structure 
[adapted from CHAPMAN and ROSSMANN (1993)]. The neighboring five-, three- and 
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twofold axes of the capsid subunit are shown. The sites indicated with red circles 
represent the differences between NADL2 and Kresse strains, exception for the 436 
site, in violet. The sites in blue represent the substitution in the new strains. The image 
was generated through the software Cn3D version 4.1. (available in 
http://www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml). The coordinates were 
retrieved from the NCBI Structure database 
(http://www.ncbi.nlm.nih.gov/Structure/index.shtml). Accession number: 1K3V 
(SIMPSON et al. 2002). 
 
The Swiss strain 15425 displayed several unique amino acid substitutions and appears 
to be distant from the other samples. These unique substitutions were also found in the 
PPV sequence 21620005_1h (GQ884035) from Europe. The relationship between 
these two samples can be observed by the proximity in the phylogenetic trees. 
In all new German and Austrian strains and in the Brazilian strain S30 the amino acid 
Threonine was found in position 436, an amino acid site located right in the 3 fold spike 
center of the capsid subunit. The higher incidence of a Threonine in the recent samples 
suggests that this amino acid is providing some adaptive advantage to the virus. 
According to the M8 model in the VP1 complete dataset, a higher selective pressure at 
this site in comparison with the whole virus genome was detected (0.998). The 
presence of this amino acid in this site has also been related to a possible decrease in 
the affinity of neutralizing antibodies (ZEEUW et al. 2007). To contribute to this 
discussion, future studies introducing mutations in these sites using the recent virulent 
strains aren need to be performed in order to determine whether these mutations are 
influencing/mediating the pathogenicity. 
On the other hand, a high identity between the β-strands within the VP sequences was 
observed. That was expected, as these regions have important functions in maintaining 
the capsid integrity or in the capsid-DNA interaction (CHAPMAN and ROSSMANN 
1993). 
In this study, a high evolutionary rate was found for PPV capsid genes (~3-4 x 10-4) 
and only a moderate evolution rate was found for PPV non-structural genes (~5 x 10-5). 
The Higher Posterior Density (HPD) data reflects the uncertainty in the analysis. In the 
capsid genes, the lower and higher HPD were quite similar to the mean rate, providing 
support to the data. The root-to-tip analysis also supports the temporal structure for 
both VP1 datasets. In contrast, the NS1 dataset revealed that a lower R-squared and 
temporal analysis could only be suggested (FIRTH et al. 2010). The HPD for this 
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dataset revealed a larger substitution rate range (10-4 to 10-7), indicating that this 
parameter could not be estimated with confidence. A similar HPD range for the 
substitution rate could also be seen in the NS1 gene for the FPLV (Figure 9), 
highlighting an uncertainty in the temporal analysis for the NS1 gene of the parvovirus 
(SHACKELTON et al. 2005). 
 
 
Figure 9. Nucleotide substitution rate per site per year of the PPV, CPV, FPLV and B19 
viruses. The gray bars represent the interval between higher and lower HPD and the 
middle line represent the mean rate. 
*HPD not determined. The bars represent the mean rate variation. 
 
It is expected that the selective pressure and the evolutionary rate should exhibit 
similar levels. In previous parvovirus studies, a strong corelation between the selective 
pressure and the substitution rate for distinct viruses or genes has been observed 
(SHACKELTON et al. 2005, SHACKELTON and HOLMES 2006). In the present study, 
the mean rate of dN/dS substitution per site data suggests that the NS1 and VP1 genes 
were under purifying selection, while the partial VP dataset was under positive 
pressure (PAML and MEGA analysis). According to all the models tested, a pressure 
order of VP1 partial > VP1 complete > NS1 complete was verified. The same relation 
was demonstrated in the PPV evolution rate. 
Recombination is one of the main diversity forces and allows genomic regions to have 
independent histories. Recombination events complicate the use of phylogenetic 
parameters such as timing events and selection pressures (AWADALLA. 2003). The 
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ubiquitous character of the PPV in association with an immune pressure could result in 
recombination events, as has been suggested by SHACKELTON et al. (2007). In our 
dataset alignments, no consensus for recombination events was found while applying 
several methods. However, incongruence in the partial structural protein dataset tree 
could be observed in comparison with the complete structural gene tree, e.g.: 225b 
(AY684864) and ZJ (EU790642) strains. The strain 225b was previously reported to be 
a possible recombinant strain originated from two distinct phylogenetic clusters 
(SHACKELTON et al. 2007). In order to avoid any false result in our timing analysis, 
the substitution rate was re-calculated without the incongruent sequences. No 
significant differences were observed. 
Traditionally, PPV is considered to be a virus with a more conservative genome than 
other parvoviruses and viruses with single-strand DNA (LUKASHOV and GOUDSMIT 
2001; LÓPEZ-BUENO et al. 2006; DUFFY et al. 2008). In a previous study, surface 
amino acid substitutions were found in German strains from 2001-2002 
(ZIMMERMANN et al. 2006). Furthermore, it was demonstrated that antibodies raised 
against the vaccine strains (strain NADL2 and IDT) have a lower neutralization activity 
against field strains (27a and 143a) with these substitutions (ZEEUW et al. 2007; 
JÓŹWIK et al. 2009). In the present study, the modifications found in these two strains 
could also be observed for the current PPV-isolates in the population, indicating that 
the vaccines may no longer be fully protective. Additionally, new surface amino acid 
substitutions were also observed. These structural modifications found in strains 
collected over the last years, may represent an escape mechanism from the inactivated 
PPV vaccine, often used in the last 30 years. Rapid evolution is already known among 
ssDNA viruses, including canine parvovirus and human B19 erythrovirus (Figure 9) 
(SHACKELTON et al. 2005; SHACKELTON and HOLMES 2006). Reasons for the 
observed high substitution rates in parvoviruses and other ssDNA viruses remain 
unclear. Unlike RNA viruses, which use their own error-prone polymerases, PPV 
replicates using the cellular DNA polymerase of the swine host, implying that they 
should have the same replication fidelity as its host. Previous studies suggest that the 
proofreading or repair mechanism may not be efficient or accurate enough in these 
genomes or in cells with an active viral infection (SHACKELTON et al. 2005; 
SHACKELTON and HOLMES 2006). Alternatively, processes like the ssDNA 
deamination due to the lack of the double helix or non-functional host exonucleases 
(resulting from the absence of proper methylation patterns) could also lead to a 
mutational vulnerability (SANZ et al. 1999; DUFFY and HOLMES 2008). 
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In agreement with our report, previous studies could also define new virus profiles with 
new amino acid substitutions (SOARES et al. 2003; ZIMMERMANN et al. 2006; 
SHANGJIN et al. 2009). These substitutions are mainly located at the capsid surface 
and the development of a distinct surface profile from the vaccine strains (mainly based 
on the NADL2 strains) can be clearly noticed. In addition, the phylogenetic tree 
associated with a molecular clock analysis revealed that the divergences between the 
main isolates were introduced for the nonstructural gene dataset in the last 100 years 
and for both structural gene datasets in the last 10-30 years. Therefore, our data 
indicates that the currently used immunization schedules with inactivated whole-virus 
vaccines may need to be discussed. In the closely related canine and feline 
parvoviruses, inactivated full virus vaccines are no longer common, and have been fully 
replaced by modified-live virus vaccines (MLV). MLVs in these animals induces a long-
lasting immune response that provides protection for at least several years and could 
also be an attractive alternative for PPV vaccination. 
 
METHODS 
PPV SAMPLES 
A total of eleven recent isolates from Austrian, Brazil, Germany and Switzerland were 
analyzed. The Austrian (693a), German (7a, 8a and 14a), Swiss (15411, 15421 and 
15425) and the Brazilian strains (PA and PB) were originated from clinical cases 
involving reproductive losses. The Brazilian strain (S30) were obtained from 55-day old 
(mean age) wasting piglets, and one (Embrapa) was isolated from an unknown source 
in Brazil. 
 
AMPLIFICATION 
The total DNA was purified from the clinical samples and the cell culture supernatant 
using the QIAamp DNA Mini kit (Qiagen, Germany), in accordance with the 
manufacturer’s instructions. The DNA was stored at -22°C until further analysis. The 
NS1 and VP1/VP2 genes amplification was performed using the primer pairs listed in 
the supplementary data. PCR was performed using ReddyMix PCR Master Mix 
(Abgene, United Kingdom) in a final volume of 50 µL. Amplification by PCR was 
performed under the following conditions: 1 cycle at 94°C for 2 min, 35 cycles of 94°C 
for 30 sec, 55°C for 40 sec and 72°C for 1 min and 1 cycle at 72°C for 5 min. PCR 
amplification products were purified using the NucleoSpin purification kit (Macherey-
Nagel, Germany) and sequenced using a BigDye terminator v 3.1 cycle sequencing kit 
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(Applied Biosystems, USA) and analized on an ABI3100 genetic analyzer (Applied 
Biosystems, USA) by Zentraler Funktionsbereich DNA-Sequenzierung (University of 
Leipzig, Germany). The DNA from the Brazilian strains was extracted using a silica-
based protocol (BOOM et al. 1990). The nested-PCR reactions were performed as 
previously described (SOARES et al. 2003) and custom sequenced as above 
described. 
The assembly of the obtained sequences to a full length sequence was performed 
using the SeqMan program of the Lasergene software (DNASTAR, USA). The 
sequences were deposited in GenBank with the accession numbers FJ643427-
FJ643430 and JN400516-JN400526. 
All nucleotide numbers used in the present study refered to the Kresse strain 
(GenBank accession number U44978). The amino acid numbers are according to the 
VP2 protein of the same strain. 
 
PPV DATASET 
All NS1 and VP gene sequences deposited in GenBank (up to September 2010), 
containing the isolation year, were retrieved from NCBI (http://www.ncbi.nlm.nih.gov/) 
using “porcine parvovirus” as keyword. These sequences, taken together with the new 
sequences described here totaled 31 complete sequences of the NS1 gene and 31 
complete sequences of the VP2 gene, which were analyzed separately. In order to 
increase the number of sequences in the analysis, a third dataset containing 65 partial 
sequences of VP2 gene was also constructed. The latter dataset consisted of 739 
nucleotides (between nucleotide position 3701 and 4439). The year of isolation from 
the Brazilian samples PA, PB and Embrapa are unknown; therefore, these samples 
were excluded from further analyses. The datasets were aligned by applying the 
ClustalW method using MEGA 4 software (TAMURA et al. 2007). Possible genetic 
recombination events between virus strains were examined using the Bootscan, 
Chimaera, GENECONV, MaxChi and SisScan methods with default parameters, 
implemented in the RPD3 software package (MARTIN et al. 2010). Details of these 
methods are given in MARTIN et al. (2010) and program manual. Recombination 
events were assumed when a consensus between three or more methods was found. 
 
PHYLOGENETIC ANALYSIS AND SELECTION PRESSURES 
CHAPTER 3 - HIGH EVOLUTION RATE IN THE PPV CAPSID PROTEIN 
33 
 
To perform the Maximum likelihood (ML) phylogenies, the DNA substitution model was 
obtained using the software ModelTest v.3.7 (POSADA and CRANDALL 1998). The 
analysis was performed with the software PAUP v.4.0.b (SWOFFORD. 2002). The 
heuristic search was performed using the Tree-Bisection-Reconnection method of 
branch swapping. Support was obtained using 100 bootstrap repetitions. The clock-like 
behavior of each data set was visualized using the regression of the root-to-tip genetic 
distance inferred from the ML trees against the sampling time in the software Path-O-
Gen v.1 (DRUMMOND et al. 2003). 
The rates of nucleotide substitution per site per year were estimated with a Bayesian 
Markov chain Monte Carlo method, using the software BEAST v.1.5.4 (DRUMMOND 
and RAMBAUT 2007). These analyses were run using the Hasegawa-Kishino-Yano 
(HKY) DNA substitution model with partitions into codon positions, performing 100 
million generations through the Markov Chain Monte Carlo (MCMC) and sub-sampling 
each 10,000 generations. The population dynamic models tested were i.: constant 
population size and ii.: Bayesian skyline coalescent model. The molecular clock models 
tested were i.: strict molecular clock, ii.: relaxed clock with an uncorrelated lognormal 
distribution of rates (UCLN) and iii.: relaxed clock with an uncorrelated exponential 
distribution of rates (UCED). Multiple runs were performed for each data set to find the 
best model fitting the data [i.e. with a higher marginal Likelihood score (SUCHARD et 
al. 2001)]. The resulting data were visually analyzed using Tracer software 
(http://tree.bio.ed.ac.uk/software/tracer/) after removing a 10% “burn in” for each data. 
A “consensus” tree for each dataset was generated by the software TreeAnnotator 
v.1.5.4 (BEAST package). Phylogenetic trees were visualized with the software 
FigTree v.1.3.1 (http://tree.bio.ed.ac.uk/). The resulting trees were sorted to facilitate 
the comparison with the previously described VP1 and VP2 gene clusters. Groupings 
with posterior probabilities ≥ 0.90 were considered to be clusters and those with 
posterior probabilities ≤ 0.90 were considered to be clades. 
The ratio of non-synonymous to synonymous nucleotide changes per site (dN/dS) for 
each branch of the phylogenetic tree was estimated for the NS1, VP1 complete and 
VP1 partial data sets using the PALM 4.2b package (YANG. 1997) following 
SHACKELTON et al. (2005) with few adjustments and using the ML tree as described 
above. A comparison of the M7 and M8 models was used to analyze selection 
pressures at specific codons in the codeml option (p > 0.001). The branch-site model 
was used to detect the positive selection acting in particular lineages/branches and 
compared with a null ω2 fixed model (p > 0.001). In addition, the modified Nei & 
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Gojobori method (NEI and GOJOBORI 1986) applied with the MEGA 4 software was 
also used to find the ratio of non-synonymous to synonymous nucleotide changes. 
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ABSTRACT 
To estimate the impact of PPV vaccines on the emergence of new phenotypes, the 
population dynamic of PPV was calculated, and an in vitro-model was designed to 
reproduce a possible immune selection. A decrease in genetic diversity was observed 
in the presence of antibodies in vitro or after vaccination. Since antibodies have 
reduced neutral selection, then the vaccine failures and infections in non-vaccinated 
populations were most likely responsible for the emergence of new PPV phenotypes. 
 
Submitted 
 
MAIN TEXT 
Porcine parvovirus (PPV) infections are characterized by the reoccurrence of estrus, 
abortion and the delivery of mummified and stillborn fetuses [summarized in TRUYEN 
and STRECK (2012)]. The resulting economic losses for the pig industry led to the 
global use of inactivated vaccines after the 1980s (TRUYEN and STRECK 2012). 
In the last 15 years, several reports have been published about new PPV-phenotypes 
with amino acid changes resulting in variations on the capsid surface (SOARES et al. 
2003; ZIMMERMANN et al. 2006; STRECK et al. 2011). These amino acid 
substitutions may be responsible for the dramatically different pathogenic properties of 
the virus (BERGERON et al. 1996). In addition, there is evidence that antibodies raised 
against most of the PPV vaccine strains displayed a low heterologous neutralizing 
activity against these new phenotypes. This led to the hypothesis that the vaccines 
may force a selective pressure on PPV field strains resulting in “escape mutants”, 
which could have supported the emergence of new phenotypes (ZEEUW et al. 2007). 
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To address the question whether PPV vaccines have influence on the emergence of 
new phenotypes, we analyzed the population dynamics of the virus in silico and the 
antibody pressure was evaluated with an in vitro-model. 
To test the hypothesis of an antigenic selection we designed an in vitro experiment in 
which polyclonal serum generated from an experimentally NADL2-infected sow was 
used to neutralize one homologous and one heterologous PPV virus isolates. The 
homologous strain used was the NADL-2 (USA), a tissue culture-adapted vaccine virus 
(MENGELING. 1975) and the heterologous strain used was the strain called 
“Challenge” (England), a virulent strain that shows only a limited crossneutralization 
with the NADL-2 strain (ZEEUW et al. 2007). The neutralization capacity of the 
polyclonal antibodies is 1:5120 for the NADL2 strain and 1:640 for the Challenge strain 
(minimal serum dilution able to neutralize 50 TCID mL-1). Both strains without 
antibodies were used as negative controls. 
The first inoculations with Challenge and NADL-2 viruses were performed in PK-15 
cell-lines (3x105 cells/mL) with a minimal concentration of virus able to produce a 
TCID50 (in 96h) and maintained in Dulbecco's Modified Eagle Medium (DMEM, Sigma–
Aldrich, Germany) supplemented with 5% (v/v) fetal bovine serum (FBS) at 37°C in 5% 
CO2. Additionally, different dilutions of polyclonal serum were added to the inoculated 
cells (hemagglutination-inhibition titer of 1:500 to 1:1.72 per 25 µL). After five days, the 
mixture with the minimal dilution of serum, but still displaying signs of CPE was 
collected and frozen. A subsequent re-inoculation of cells with different serum dilutions 
was performed with the collected viruses. After another five days, cells with the minimal 
dilution of serum and still presenting signs of CPE were collected again. This process 
was repeated for 21 passages. In the control, both viruses were inoculated in cells 
without polyclonal serum, collected, frozen and further passed this way for 21 times. A 
resistance was observed in the homologous NADL2 and heterologous Challenge 
strains inoculated with the antibodies in the last two passages, and a cytopathic effect 
was evident even in the most concentrated antibody dilution (1:500). Thus, no further 
passages were performed. The DNA amplification, sequencing, and assembly were 
performed as previously described (STRECK et al. 2011). The sequences were 
deposited in GenBank under the accession numbers (waiting for approval). 
The VP gene sequence analysis revealed that the viruses grown without antibodies 
had more substitutions than the viruses cultivated with antibodies after 21 passages 
(Table 3). That was more evident in the homologous NADL2 strain without antibody 
pressure (with one synonymous and six non-synonymous substitutions) compared to 
the NADL2 submitted to antibody pressure (two synonymous substitutions). For the 
heterologous Challenge, the differences were blander: three synonymous and three 
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non-synonymous substitutions for the virus without the antibody pressure and three 
synonymous and two non-synonymous substitutions for the virus submitted to the 
antibody pressure. 
 
Table 3. Nucleotide (nuc.) and amino acid (aa.) substitution for the homologous NADL2 
and heterologous Challenge strains after 21 passages with and without antibody (AB) 
pressure. 
CHAPTER 4 - POPULATION DYNAMICS OF PPV 
40 
 
 
Nuc. position number 2551 2746 2943 3163 3242 3383 3522 3635 3768 3942 3958 4030 4115 4183 4474 4503 
NADL2 original GAA AGA ACT GGA ATA AGT CTA TTA ATT GAT CAC AAG TCT CCT AAC AGA 
NADL2 with AB 
        
AGT 
 
CAA 
     
NADL2 without AB 
       
CTA ACT GGT CAA AAC 
  
AAA AAA 
AA. position number 63A 128A 45B 118B 145B 192B 238B 276B 320B 378B 383B 407B 436B 458B 555B 565B 
NADL2 original E R T G I S L L I D H K S P N R 
NADL2 with AB 
        
S 
 
Q 
     
NADL2 without AB 
        
T G Q N 
  
K K 
Nuc. position number 2551 2746 2943 3163 3242 3383 3522 3635 3768 3942 3958 4030 4115 4183 4474 4503 
Challenge original GAG AGA AGT GGG ATA AGT CTA TTA ATT GGT CAA AAG CCT CCC AAC AAA 
Challenge with AB GAA 
 
ACT GGA 
        
TCT CCT 
 
 
Challenge without AB GAA AGG 
  
CTA GGT CCA 
      
CCT 
  
AA. position number 63A 128A 45B 118B 145B 192B 238B 276B 320B 378B 383B 407B 436B 458B 555B 565B 
Challenge original E R S G I S L L I G Q K P P N K 
Challenge with AB 
  
T 
         
S 
 
 
 
Challenge without Ab 
    
L G P 
         
AAmino acids numbers from VP1 protein 
BAmino acids numbers from VP2 protein 
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Most of the changes were observed in positions known to be under a high selective 
pressure (SHANGJIN et al. 2009). In the amino acid position 320 (isoleucine), a serine 
was inserted in the NADL2 virus submitted to the antibody pressure and a threonine in 
the NADL2 virus grown without the antibody pressure, indicating that this site is highly 
variable. Additionally, in site 436 of the Challenge virus grown with antibody pressure, a 
serine was inserted (presented also in the original NADL2 strain). This site is located at 
the top of the 3-fold spike and is considered to have a high binding potential to 
antibodies (SIMPSON et al. 2002). Since antibodies raised against the NADL2 virus 
should now be able to strongly bind the Challenge virus with this substitution, this 
change was not expected. Despite the antibody pressure, the P436S substitution may 
have been selected because of replication advantages. A previous study with different 
chimaeras between the virus Kresse and NADL2 revealed that genetic elements of the 
NADL2 virus (including the site 436) are responsible for the replication efficiency in cell 
lines (FERNANDES et al. 2011). 
For the in silico analysis, all VP gene sequences deposited in the GenBank (up to May 
2012) were retrieved from NCBI (http://www.ncbi.nlm.nih.gov/). Only viruses originally 
isolated from swine were considered. The dataset consisted of 739 nucleotides 
(between nucleotide position 3701 and 4439) from 74 samples. The nucleotide and 
amino acid numbers used in this study are based on the Kresse strain (GenBank 
accession number U44978). 
The clock-like behavior of the dataset was visualized using the regression of the root-
to-tip genetic distance inferred from the Maximum Likelihood tree against the sampling 
time in the software Path-O-Gen v.1 (DRUMMOND et al. 2003). The population 
dynamic was estimated with a Bayesian Markov chain Monte Carlo (MCMC) method, 
using BEAST version 1.7.1 (DRUMMOND and RAMBAUT 2007). These analyses were 
run using the GTR DNA substitution model with partitions into codon positions, 
performing 500 million generations through the MCMC and subsampling each 10 000 
generations. The population dynamic model used was the Bayesian skyline coalescent 
(stepwise) model and the molecular clock model used was a relaxed clock with an 
uncorrelated log-normal distribution of rates. Additionally, different models testing the 
population size change through time were estimated (constant, lineal and stepwise) 
using the GTR DNA substitution model with partitions into codon positions, performing 
10 million generations through the MCMC and subsampling each 10 000 generations. 
The fitness of both models was compared using the marginal likelihood, adopting the 
method of NEWTON AND RAFTERY (1994), with modification (SUCHARD and 
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REDELINGS 2006). The strength of the statistical evidence was quantified using the 
Bayes factors (KASS and RAFTERY 1995). 
The root-to-tip analysis was constructed to examine whether the samples exhibited 
adequate temporal structure. Since the obtained value of R2 for the regression analysis 
was 0.9845, a strong temporal fitness was confirmed for the dataset. Finally, the 
Bayesian skyline coalescent model was used to estimate the epidemiological history 
and evolutionary dynamics of the PPV over time. The comparison of the null 
hypothesis (constant population size) with the hypothesis in which population change is 
allowed indicated that the data fit better with the hypothesis that allow variability (Table 
4). The resulting demographic inference is shown in Figure 10. The effective population 
size of PPV underwent a period of relative steadiness until around 1982. After 1982, a 
moderate but continuous decrease is evident until the recent strains. The beginning of 
the population decrease matches with the period in which vaccination campaigns were 
broadly introduced. 
 
 
Figure 10. Skyline plot of the PPV population dynamics. The solid black line represents 
the mean value of the skyline plots. The blue area represents the limits of 95% higher 
posterior probability density. Time is shown in years across the X bar and the effective 
population size is shown in the Y bar. 
CHAPTER 4 - POPULATION DYNAMICS OF PPV 
43 
 
 
Table 4. Comparison of the null-hypothesis (constant population size) with the 
hypothesis that allows population variability. 
 
Model 1 Model 2 Model 3 
Tree prior Constant Lineal Stepwise 
Maximum likelihood -1770.3356 -1772.9462 -1762.8145 
95% higher posterior 
probability density difference 
49.00 43.66 43.56 
Log 10 Bayes’ factor* 2.488 0.851 - 
*Values between 0.0-0.5 provide no evidence; 1.0-1.5 provide weak evidence; >1 
provide strong-to-decisive evidence [adapted from van BALLEGOOIJEN et al. (2009) 
and KASS and RAFTERY (1995)]. 
 
A main explanation for this phenomenon could be the broad use of certain PPV 
vaccines in the last 30 years. This can be stipulated, since a reduction in the genetic 
diversity is assumed to be strictly related to a more difficult or reduced virus 
transmission (HALLORAN and HOLMES 2009; van BALLEGOOIJEN et al. 2009), as 
expected in a vaccinated population. Another important factor that can influence the 
genetic diversity of the virus is the behavior of the host population (HALLORAN and 
HOLMES 2009). In the last decades, the demographics of the virus infection and its 
spreading potential with larger swine breeding/growth facilities possible changed. 
Additionally, new sanitary measures and disinfectants were adopted in the 1980s, 
probably affecting the viral population dynamics as well. 
As several other factors could have influenced the PPV dynamic in the last decades, 
the in vitro-model was used to show that antibody pressure is able to cause a higher or 
lower genetic drift. In that model, we expected to observe a viral escape mechanism in 
viruses submitted to the antibody pressure. However, for both strains (NADL2 and 
Challenge), we observed less nucleotide and amino acids substitutions in the viruses 
when cultivated under antibody pressure in comparison with the same viruses 
cultivated without this pressure. This was particularly evident for the NADL2 strain 
submitted to the homologous antibody pressure. Regarding the heterologous 
Challenge strain, the emergence of non-synonymous and synonymous substitutions 
was quite similar for the virus cultivated with and without antibodies. As antibodies 
raised against the NADL2 virus do not efficiently neutralize the Challenge virus 
(ZEEUW et al. 2007; JÓŹWIK et al 2009), the pressure implemented by the anti-
NADL2-antibodies should be milder compared to that raised against the homologous 
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strain NADL2. Under a strong pressure, most mutations may be deleterious, and the 
genetic diversity was lower for the NADL2 strain. 
The selective forces that drive parvovirus evolution remain uncertain. Apparently, as in 
the in vitro-model a lower genetic diversity was observed in the presence of antibodies 
neutral selection seems to be more important for PPV than adaptive evolution. 
In wild boar populations, phylogenetic analysis indicated that PPV is more diverse than 
in domestic pigs (CADAR et al. 2012). The authors of that study observed that the 
amino acid substitution rate per year was higher than that found in a study examining 
samples from domestic pigs (STRECK et al. 2011). As possible explanations for the 
wild boar viruses’ higher variability, the dissemination of the same virus in herds by 
mixing animals of different sources and the extensive vaccination in domestic swine 
were hypothesized as factors that reduce PPV variability in these populations. Taken 
into consideration with the findings in the in vitro and in silico models, it can be 
assumed that vaccine failures and non-vaccinated populations (e.g. wild boars) rather 
than escape mutations due to vaccine-pressure may have played a major role in the 
emergence of new PPV-phenotypes. 
In conclusion, the widely used vaccination programs had influenced the genetic 
diversity of porcine parvoviruses. To further minimize the risk of the emergence of new 
phenotypes the use of homologous vaccines along with a constant monitoring of the 
PPV appears advisable. 
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ABSTRACT 
In the present study, tonsils and hearts from 100 pigs were collected in a German 
slaughterhouse in 2010 and tested for porcine parvoviruses (PPV, PPV2, PPV3 and PPV4). 
PPV was observed in 60/100 hearts and 61/100 tonsils and, PPV2 in 55/100 hearts and 
78/100 tonsils. PPV3 and PPV4 were found in 20/100 and 7/100 of the tonsils tested, but not 
in the heart samples. Positive samples of PPV, PPV2 and PPV3 were analyzed by 
nucleotide sequencing and their phylogenetic analysis revealed at least two distinct lineages 
for each virus in the German samples. The high detection rate of the PPV, PPV2 and PPV3 
in healthy animals and their genetic diversity highlights the importance of the continuous 
monitoring of these viruses and their zoonotic potential. 
 
Archives of Virology, 2012, Accepted 
 
INTRODUCTION 
Parvoviruses are small DNA viruses infecting a variety of animal hosts, in which they may 
cause asymptomatic or sub-clinical infections as well as severe or even fatal disease. These 
viruses belong to the Parvoviridae family, which is sub-classified into two subfamilies: 
Densovirinae and Parvovirinae (TIJSSEN et al. 2001). The latter containing the most 
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important genera for the veterinary and human medicine in the whole family (Amdovirus, 
Bocavirus, Dependovirus, Erythrovirus and Parvovirus). 
Porcine parvovirus (PPV) is considered to be one of the major causes of reproductive failure 
in swine. Clinical signs of PPV infections are characterized by the reoccurrence of estrus, 
abortion and the delivery of mummified and stillborn fetuses [reviewed by TRUYEN and 
STRECK (2012)] usually described with the acronym SMEDI (stillbirth, mummification, 
embryonic death and infertility). It was already demonstrated that PPV has a high substitution 
rate in the capsid gene, similar to that in other parvoviruses and in RNA viruses 
(SHACKELTON and HOLMES 2006; SHACKELTON et al. 2005; STRECK et al. 2011a). 
Therefore, the emergence of new PPV strains may interfere with the efficacy of the currently 
used vaccines, recommending the continuous monitoring of the swine population for PPV. 
In recent years, by means of molecular techniques, the DNA sequences of several novel 
viruses have been identified. For parvoviruses affecting swine, the first of the newly identified 
viruses was the virus H-1 in sera from pigs in Myanmar (HIJIKATA et al. 2001), originally 
described as porcine parvovirus 2 (PPV2). In 2008, a virus closely related to the human 
parvovirus 4 was found in slaughtered pigs in Hong Kong (LAU et al. 2008) and initially 
termed as porcine hokovirus, here designated as porcine parvovirus 3 (PPV3). In 2010, 
another parvovirus was found in lungs from a diseased pig co-infected with porcine circovirus 
type 2 and designated porcine parvovirus 4 (PPV4) (CHEUNG et al. 2010). The impact of 
these viruses for the pig industry remains unknown. 
In order to monitor the occurrence of new strains of PPV and to study the distribution of novel 
parvoviruses (PPV2, PPV3 and PPV4), hearts and tonsils of clinically healthy swine were 
collected at a slaughterhouse and examined for these viruses. 
 
MATERIAL AND METHODS 
SAMPLES 
Tonsils and hearts (apex) from 100 pigs (around six months old) were collected in a German 
slaughterhouse in December 2010. The animals originated from thirteen farms (here termed 
A to M) located in seven German Federal States (Hessen, Lower Saxony, Mecklenburg-
Vorpommern, Saxony, Saxony-Anhalt, Schleswig-Holstein and Thuringia). One gram of each 
tissue was macerated using mortar and pestle and resuspended as a 20% (v/v) suspension 
in phosphate-buffered saline solution (PBS, pH 7.2). Homogenates were cleared by 
centrifuging at 4000 g for 5 min and filtered (0.2 µm pore size). Clarified supernatants (200 
µL) were used for total nucleic acid extraction using the QIAamp DNA Mini kit (Qiagen, 
Germany), according to the manufacturer´s instructions. 
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DNA AMPLIFICATION AND SEQUENCE ANALYSIS OF THE VP-GENE AND FULL-
LENGTH GENOMES 
Primers for the PPV2, PPV3 and PPV4 (Table 5) were designed using the Primer3 program 
(http://primer3.sourceforge.net/). The selected primers were locally aligned using the BLAST 
algorithm (http://blast.ncbi.nlm.nih.gov/Blast.cgi) against the GenBank content to avoid 
homology with other viral sequences. The PCRs specific for PPV, PPV2, PPV3 and PPV4 
were carried out in single reactions using 10 nmol from each dNTP (Rapidozym, Germany), 
10 pmol of the respective primer pair (Table 5), one unit of Taq polymerase (Rapidozym, 
Germany), enzyme buffer (according to the manufacturer’s instruction) and 2 µL of DNA 
template in a total volume of 25 µL completed with bi-distilled water. The amplification was 
performed with an initial heating at 95°C for 2 min utes, followed by 35 cycles consisting of 30 
seconds at 95°C for denaturation, 30 seconds at 55° C for annealing, 30 seconds at 72°C for 
extension, and a final extension at 72°C for 5 minu tes. Amplification products were submitted 
to electrophoreses in 1.5% agarose gels with 89 mM Tris-Base, 89 mM of boric acid, 2 mM 
EDTA Na2 (TBE, pH 8.0) buffer and stained with 1,5 µL (per 100 mL of agarose gel) of Midori 
Green DNA Stain (Nippon Genetics Europe, Germany). 
 
Table 5. Primers for the detection of the PPV, PPV2, PPV3 and PPV4. 
Primer Sequence Location 
PPV_S GGGGGAGGGCTTGGTTAGAATCAC 2974-2997 
PPV_AS ACCACACTCCCCATGCGTTAGC 3149-3170 
PPV2_F AGATTCTTGCAGGCCGTAGA 909-928 
PPV2_R CCAAGGGTCAGCACCTTTTA 1096-1115 
PPV3_F GTGGCAGTGATATTGCATCG 992-1011 
PPV3_R TGGCAGTCATTGAATGGAAA 1219-1238 
PPV4_F ACAAGGTGGAGGAACGTTTG 3069-3088 
PPV4_R TTCCATGAGGGAGAGGATTG 3289-3308 
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In order to determine the sensitivity of each PCR, a plasmid harboring the target sequence of 
each PCR was generated. Briefly, PPV2, PPV3 and PPV4 positive samples were amplified 
as described previously. The amplicons were purified with the NucleoSpin purification kit 
(Macherey-Nagel, Germany) and cloned into the pDRIVE vector (Qiagen, Germany) using 
One Shot® TOP10 Chemically Competent E. coli (Invitrogen, Germany). The transformed 
cells were grown on LB (Luria Bertani, Carl Roth GmbH, Germany) plates supplemented with 
100 µg/ml ampicillin and incubated overnight at 37°C. Positive colonies were subcultured in 
LB broth (Carl Roth GmbH, Germany) with ampicillin and incubated at 37°C for 8 hours. 
Plasmids were extracted using the PeqGOLD Plasmid Miniprep Kit I (Peqlab, Germany) and 
quantified by UV spectroscopy. For PPV, a plasmid containing the whole virus (Kresse 
strain) was used (FERNANDES et al. 2009). The copy number of each plasmid was 
calculated according the equation described in WHELAN et al. (2003). Finally, successive 
10-fold dilutions of each plasmid were performed and tested for the respective PCR reaction. 
Randomly selected positive samples of PPV, PPV2 and PPV3 were further amplified using 
the primer pairs listed in Supplementary Table 1. PCR was performed using the HotStarTaq 
Master Mix Kit (Qiagen, Germany) in a final volume of 25 µL. The PCR was performed under 
following conditions: one cycle at 94°C for 15 min followed by 40 cycles of 95°C for 1 min, 
55°C for 1 min and 72°C for 1 min, with final elong ation at 72°C for 5 min. PCR products 
were purified using the NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel, Germany), 
sequenced using a BigDye Terminator version 3.1 Cycle Sequencing kit (Applied 
Biosystems, Germany) and analyzed on an ABI3100 Genetic Analyzer (Applied Biosystems, 
Germany) at the Zentraler Funktionsbereich DNA-Sequenzierung (University of Leipzig, 
Germany). Assembling of the obtained sequences to a full-length sequence was performed 
using the SeqMan program of the Lasergene software (DNASTAR). The nucleotide 
sequences of the complete VP1 gene of the PPV and nearly full-length genomes of the 
PPV2 and PPV3 viruses were submitted to the NCBI GenBank, and are available under the 
accession numbers KC296743- KC296752. The samples were named according their 
sample number (1 to 100), followed by an H (sample from heart) or a T (sample from tonsil) 
and the respective virus (PPV, PPV2 or PPV3). 
 
PHYLOGENETIC ANALYSIS 
Sequences deposited in GenBank (up to June 2012) were retrieved from the NCBI 
homepage (http://www.ncbi.nlm.nih.gov/). In addition, the samples generated in this study 
were included. Altogether, the PPV dataset consisted of 47 sequences of the VP1 gene. In 
this dataset only sequences isolated after 2002 and standard sequences (143a, 225b, 27a, 
NADL2 and Kresse strains) were used. The PPV2 and PPV3 datasets consist of 7 and 45 
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sequences of the putative VP gene, respectively. The Open Reading Frames (ORFs) were 
found with Artemis software (RUTHERFORD et al. 2000) and the alignment was performed 
with the MUSCLE software (EDGAR. 2004). 
The phylogeny was estimated with a Bayesian Markov Chain Monte Carlo (MCMC) method, 
using BEAST version 1.7.2 (DRUMMOND and RAMBAUT 2007). These analyses were run 
using the GTR substitution model with partitions into codon positions, performing 10 million 
generations through the MCMC and sub-sampling each 1000 generations. The resulting data 
were analyzed using Tracer software (http://tree.bio.ed.ac.uk/software/tracer/) after removing 
a 10% “burn in” for each data and compared with different priors. A maximum clade 
credibility tree for each dataset was generated by the software TreeAnnotator v.1.7.1 
(BEAST package). Phylogenetic trees were visualized with the software FigTree v.1.3.1 
(http://tree.bio.ed.ac.uk/). 
All nucleotide numbers used in the present study for the PPV refer to the Kresse strain 
(GenBank accession number U44978). Amino acid numbers are according to the VP2 
protein of the same strain. The nucleotide number for the novel parvoviruses refer to: PPV2 
strain YH14 (GU938301), PPV3 strain HK1 (EU200671) and PP4 strain JS0918-5598 
(GU978966). 
 
CELL CULTURES 
For virus isolation, the following cell lines were used: porcine kidney 15 (PK-15, CCL-33), 
swine embryonic kidney (SPEV) and swine testicular epitheloid (STE, CRL 1746). PK-15 and 
SPEV cells were propagated in Dulbecco's Modified Eagle Medium (DMEM, Sigma–Aldrich, 
Germany) supplemented with 5% (v/v) Fetal Bovine Serum (FBS), grown and maintained at 
37°C in 5% CO 2. STE cells were cultivated in DMEM supplemented with 10% (v/v) FBS and 
grown and maintained at 37°C. For primary cultures,  testicles, lungs and kidney from piglets 
(negative tested for PPV, PPV2, PPV3 and PPV4) were washed in PBS (pH 7.2) and 
gingerly minced. The enzymatic disaggregation was performed with Trypsin 0.25% (Sigma–
Aldrich, Germany) agitated using a magnetic stirrer at 37°C for 45 min. The cells were then 
clarified (centrifugation at 500 g for 5 min), propagated in DMEM supplemented with 10% 
(v/v) FBS and grown and maintained at 37°C in 5% CO 2. Finally, blood was obtained from 4 
months old pigs and peripheral blood lymphocytes were separated from heparinized blood 
on Ficoll-Hypaque (Sigma–Aldrich, Germany). After one wash with PBS (pH 7.2) and 
clarification (600 g per 5 min) the cells were resuspended in Roswell Park Memorial Institute 
Medium (RPMI 1640, Sigma–Aldrich, Germany). Non-adherent cells were collected and 
resuspended in RPMI 1640 medium plus 20 µg/mL of concanavalin A (Lektin, Applichem, 
Germany). 
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All cell-lines and cell-cultures were inoculated with 100 µL of the inoculum (macerated 
tissues, Supplementary Table 3), after five days of incubation the cells were frozen and 
thawed twice and 500 µL of this mixture were used to inoculate new cells. The second cell 
passage was incubated for 5 days and frozen-thawed twice again. DNA of the cell extract 
and medium surface was extracted and submitted to the PCR. 
 
STATISTICAL ANALYSIS 
The data were statistically analyzed using the Chi-Square-test to evaluate differences in the 
PCR results. All analyses were carried out using the statistical package IBM-SPSS Version 
20. Values of P < 0.05 were considered statistically significant. 
 
RESULTS 
PCR 
The sensitivities of the PCRs was determined to be 10, 50, 100 and 50 plasmid copies 
detected per reaction for PPV, PPV2, PPV3 and PPV4, respectively. As shown in Table 6, 
amplification products of the PPV could be observed in 60/100 hearts and 61/100 tonsils. 
PPV2 could be identified in 55/100 hearts and 78/100 tonsils. None of the heart samples but 
20/100 tonsil samples were positive for PPV3. Furthermore, none of the hearts was positive 
for PPV4 whereas in 7/100 a positive result was observed in tonsils. In total, 77 animals were 
positive tested for PPV, 81 for PPV2, 20 for PPV3 and 7 for PPV4. 
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Table 6. Positive samples for the PPV, PPV2, PPV3 and PPV4 viruses according their 
respective herd (A-M) and federal state (HE: Hessen, NI: Lower Saxony, MV: Mecklenburg-
Vorpommern, SN: Saxony, ST: Saxony-Anhalt, SH: Schleswig-Holstein and TH: Thuringia). 
Results displayed as (positive heart samples//positive tonsil samples). 
Herd Fed. State PPV PPV2 PPV3 PPV4 
A (n=10) TH 7//4 3//4 0//0 0//2 
B (n=10) MV 8//10 8//9 0//0 0//0 
C/D (n=10) SN 10//9 7//10 0//5 0//1 
E/F (n=10) NI 8//6 5//8 0//4 0//0 
G (n=10) ST 2//0 5//10 0//0 0//1 
H (n=10) SH 6//9 5//5 0//2 0//0 
I (n=10) HE 8//7 3//5 0//5 0//0 
J/K (n=10) HE/NI 8//10 5//8 0//0 0//2 
L (n=10) NI 1//6 5//9 0//4 0//1 
M (n=10) SN 2//0 9//10 0//0 0//0 
Total 
 
60a//61a 55b//78b 0//20 0//7 
Upper letters showed statistical association. 
 
In the heart samples, PPV and PPV2 co-infection was observed in 32/100 samples. In the 
tonsils, the greatest numbers of viral co-infection was observed for the PPV together with 
PPV2 (46/100), PPV together with PPV3 (15/100) and PPV2 together with PPV3 (15/100) 
(Table 7). Co-infection with PPV, PPV2 and PPV3 was observed in 12/100 samples and 
2/100 samples were positive tested for the four viruses. No contamination was observed in 
the negative controls. 
 
Table 7. Number of positive samples for each virus per tissue 
 
Heart 
 
Tonsil 
Virus PPV PPV2 PPV3 PPV4 
 
PPV PPV2 PPV3 PPV4 
PPV 60 
    
61 
   
PPV2 32 55 
   
46 78 
  
PPV3 0 0 0 
  
15 15 20 
 
PPV4 0 0 0 0 
 
4 5 2 7 
 
GENETIC CHARACTERIZATION 
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The four sequences of the PPV VP1 gene analyzed (6T-PPV, 37T-PPV, 55T-PPV and 80T-
PPV) show an identity of 98.4% - 100% with the sequences retrieved from the GenBank 
(altogether 47 PPV sequences, nucleotide number 2287 - 2314 joined with 2388 - 4549). 
Among the four sequences of this study the nucleotide identity ranged from 98.4% to 99.9%. 
The synonymous substitution rate ranged from two to 21 (overall average of fourteen) and 
the non-synonymous substitution rate from zero to fourteen (overall average of nine). For 
PPV2, the three sequences (6T-PPV2, 68T-PPV2 and 98T-PPV2) showed an identity of 
94.4% - 98.7% with the sequences available (altogether seven PPV2 sequences, nucleotide 
number 240 - 5358).The identity between the three sequences was 94.7% - 98.4%. For 
PPV3, the three sequences (62T-PPV3, 70T-PPV3 and 85T-PPV3) had an identity of 95.3% 
- 99.7% with the sequences available (altogether 34 PPV3 sequences, nucleotide number 
109 - 4180). Among the three sequences, the identity was 97.4% - 99.2%.  
At the protein level, the PPV sequences 6T-PPV and 55T-PPV displayed a higher number of 
amino acid differences than 37T-PPV and 80T-PPV compared with standard strains (NADL2 
and Kresse). A similar amino acid profile can also be found in the PPV strains 15425 
(GenBank accession number JN400520) and 21620005_1h (GQ884035). On the other hand, 
the sequences 37T-PPV and 80T-PPV were almost identical to the virulent 27a strain 
(differences only at the sites A414S and E419Q) (Table 8). 
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Table 8. Amino acid substitution within PPV VP2 sequences. 
VP sequence 
Amino 
acid VP2 
NA
DL
2 
Kr
e
ss
e 
27
a
 
15
42
5 
6T
 
37
T 
55
T 
80
T 
20 T - - A A - A - 
45 T S S S S S S S 
82 R - - K K - K - 
215 I T T T T T T T 
226 Q - - E - - E - 
228 Q - E - - E - E 
233 S - - - T - T - 
304 P - - T T - T - 
320 I - - T T - T - 
366 D - - N N - N - 
378* D G G G G G G G 
383* H Q Q Q Q Q Q Q 
407 K - - N N - N - 
414 A - S - S - S - 
419 E - Q - Q - Q - 
436* S P T P P T P T 
565 R K K K K K K K 
*Site considered responsible for the different tissue tropism (BERGERON et al. 1996). 
 
PHYLOGENETIC ANALYSIS 
In the phylogeny, groups with posterior probability ≥ 0.90 were designated clusters and 
groups with low posterior probability (< 0.90) were designated clades. The Bayesian 
maximum clade credibility tree generated for the complete VP1 gene of the PPV revealed 
three clusters [here called A-PPV, B-PPV and D-PPV (posterior probability = 0.99, 0.97 and 
0.97)] and two different clades [C-PPV and E-PPV (posterior probability < 0.90)]. The 
sequences 6T-PPV and 55T-PPV were located in the cluster D-PPV and the sequences 37T-
PPV and 80T-PPV were located in the cluster A-PPV. From the sequences (isolated after 
2002), the cluster A-PPV contains the higher proportion of new sequences in the DNA 
databanks (Figure 11). 
The tree generated for the PPV2 putative VP gene displayed two clusters [A-PPV2 and B-
PPV2 (posterior probability = 0.99 and 0.99]. The sequence 68T-PPV2 was located in the 
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cluster A-PPV2 and the sequences 6T-PPV2 and 98T-PPV2 were located in the cluster B-
PPV2. Additionally, cluster A-PPV2 was formed with the sequence from Myanmar while 
cluster B-PPV2 by sequences from China. Finally, the tree generated for the PPV3 putative 
VP gene revealed two main clades [A-PPV3 and B-PPV3 (posterior probability < 0.90)]. The 
sequences 62T-PPV3 and 70T-PPV3 were located in the clade A-PPV3 and the sequence 
85T-PPV3 was located in the clade B-PPV3. Clade A-PPV3 was formed mostly by 
sequences from China and clade B-PPV3 included sequences from Germany, Romania and 
the United Kingdom. 
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PPV2 
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PPV3 
 
 
Figure 11. Phylogenetic tree for the PPV, PPV2 and PPV3 datasets. The scale axis indicates 
the substitutions per site. Posterior probabilities are indicated above the mainly branches. 
The GenBank accession number of each sequence is followed by the name (identification) 
and the location of isolation. The location is coded as: AUS (Austrian), CH (China), EU 
[Europe (no precise location available)], GE (Germany), MY (Myanmar), RO (Romania), SW 
(Switzerland), UK (United Kingdom) and USA (United States). The sequences from the 
present study are indicated with a black dot. 
 
CELL CULTURE 
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After two passages in PK-15, SPEV and STE cell-lines and as well as in the primary culture 
(kidneys, lungs, testes and macrophages) no virus specific CPE was observed and no 
specific amplicons for PPV, PPV2, PPV3 or PPV4 could be generated in the PCR 
(supernatant and cell debris). 
 
STATISTICAL ANALYSIS 
Statistical associations among hearts and tonsils samples were observed for PPV and PPV2, 
individually. No statistical association was observed among different viruses (co-infection 
between PPV, PPV2, PPV3 or PPV4). 
 
DISCUSSION 
The high PPV DNA prevalence in hearts and tonsils observed in healthy fattening pigs was 
unexpected, since at that age these animals are usually separated from the sows (which can 
shed highly contaminated material from abortions). The animals were not vaccinated against 
PPV and, as in Germany no PPV live vaccines are licensed, the probability of vaccine DNA 
detection is minute. 
Samples of tonsils were chosen due to their predominant role in a PPV infection. Tonsils are 
considered to be a primary replication site for PPV (TRUYEN and STRECK 2012). The high 
PPV prevalence (> 50%) may indicate a function of secondary replication for this tissue as 
well. As myocardium has been reported to support live-long presence of the human 
parvovirus B19 (KUETHE et al. 2009) and canine parvovirus (WALDVOGEL et al. 1991), 
heart samples were also included in the present study. In humans, prevalence of low DNA 
level of parvovirus B19 in the myocardium is a frequent finding in patients with heart disease 
and also in healthy patients (LOTZE et al. 2010). In pigs, PPV has already been 
demonstrated by nested-PCR in hearts of piglets presenting a non-suppurative myocarditis 
(BOLT et al. 1997), but its etiologic role is unknown. 
The prevalence of low level of parvoviral DNA in humans is hypothesized to be caused by 
DNA of non replicating defective interfering particles or site specific integration in the 
chromosome (SÖDERLUND-VENERMO et al. 2002). In the swine host, the presence of the 
PPV DNA in serum with no correlation with the antibodies titers was already demonstrated 
(STRECK et al. 2011b), suggesting accordance with the hypothesis of DNA defective 
interfering particles, which are not capable of any immune system stimulation. Further 
studies should be performed in order to characterize the mechanism of persistence of PPV 
and parvovirus B19. 
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As the novel porcine parvoviruses are phylogenetically closely related to the novel human 
parvoviruses, those porcine viruses have recently been investigated. For PPV2, a high 
prevalence (20.7%) was already reported in pig lungs in USA in 2011 (XIAO et al. 2012). 
Here, even higher detection rates were obtained from hearts (55%) and tonsils (78%), 
strongly indicate that these tissues may be important for the viral infection. For PPV3, a high 
detection rate (18.7%) was observed in lungs from growing-finishing pigs in the USA [26]. In 
Germany, this virus was also detected in liver and serum (32.7%) from wild boars 
(ADLHOCH et al. 2010). For PPV4 only low detection rates were observed, confirming other 
reports (HUANG et al. 2010). Coincidently, in healthy humans a similar low to moderate DNA 
prevalence is observed for Human parvovirus 4 (high nucleotide identity to the PPV3) and 
Human bocavirus (with a similar genome structure to the PPV4) and a high prevalence is 
observed for parvovirus B19 as well (CORCIOLI et al 2010; KUETHE et al 2011). 
To examine the properties of the infection in heart and tonsils, several cell-lines and primary 
cell cultures were inoculated with sixteen PCR-positive samples from PPV, PPV2, PPV3 and 
PPV4 (from tonsils and heart). PPV was firstly reported as a contaminant particle of primary 
cell culture from kidney and testicle and replication of PPV in these cells was essential for the 
further understanding of PPV biology {see SIEGL. (1976) for review}. Thus, it was expected 
that the novel parvoviruses have similar properties. The lack of virus replication in these cells 
may be due to the detection of non-infective particles of viral DNA or the primary cell cultures 
and the cell lines lack some property needed for the replication. Further studies are ongoing 
to define the tissue tropism of these viruses. 
In the phylogenetic analysis, due to the high number of PPV sequences available from 
GenBank, the tree generated for the complete VP1 gene was calculated with sequences 
derived during the last ten years. In comparison with a previous phylogenetic study with PPV 
samples collected until September 2010 (STRECK et al. 2011a) a new clade (E-PPV) was 
formed with moderate posterior probability (0.70). To the standard strains 27a (sequence 
located in cluster A-PPV) and 225b (sequence located in cluster D-PPV) the in vivo 
pathogenicity was experimentally confirmed. Additionally, it was shown that antibodies raised 
against the vaccine strains have a low neutralization activity against these strains (ZEEUW et 
al. 2007), but no information about cross-neutralization and virulence of strains from the 
cluster B-PPV and clade E-PPV is available. 
At the protein level, the sequences 37T-PPV and 80T-PPV were similar to the virulent strain 
27a (AY684871). This strain was first detected in 2001 in Germany (ZIMMERMANN et al. 
2006) and has since then been reported in several countries (STRECK et al. 2011a). The 
samples 6T-PPV and 55T-PPV had higher similarity with the strain 15425, a new strain 
(STRECK et al. 2011a), with unknown biological properties. A previous study with different 
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PPV-single-mutants has shown that the presence of amino acids 228 (E) and 436 (T) (as 
observed in the samples 37T-PPV and 80T-PPV) as well as the amino acids 414 (S) and 419 
(Q) (as for samples 6T-PPV and 55T-PPV) increased the replication efficiency in vitro 
compared to the NADL2 original strain (data not shown). The amino acids 226 (E) in the 
sample 55T-PPV as well as the amino acids 233 (T), 304 (T), 320 (T), 366 (N) and 407 (N) 
for the samples 6T-PPV and 55T-PPV are located in the loops two, three and four of VP2 
protein (Protein Data Bank accession 1K3V), it can be speculated that these substitutions 
may influence the immunogenicity or replication efficiency as well. For all the new samples, 
the amino acids substitutions (I-215-T, D-378-G, H-383-Q, S-436-P and R-565-K) that 
distinguish the non-virulent NADL2 strain (L23427) from the virulent Kresse strain (U44978) 
were similar to the Kresse sequence. The only exception was the site 436, at which the 
samples 37T-PPV and 80T-PPV have a serine (as in the strain 27a). 
For the PPV2, there are few reports to enrich our phylogenetical analyses. It seems possible 
that the virus is divided in two main clusters; however, more sequences are needed to come 
to any meaningful conclusion. For PPV3, two distinct clades are evident. One is formed 
mostly by samples from China and the other includes samples from Canada, Germany and 
Romania. In Germany, five almost identical samples from PPV3 were already observed in 
wild boars (ADLHOCH et al. 2010) and were similar to the sequence 85T -PPV3 described 
here. The PPV2 and PPV3 sequences from this study were highly diverse, indicating that 
there is no geographic predominance of a single lineage of PPV2 or PPV3 in Germany. 
In conclusion, DNA of PPV as well as of the novel PPV2, PPV3 and PPV4 was present in 
healthy animals (tonsils and hearts) and the phylogenetic analysis of the PPV, PPV2 and 
PPV3 demonstrated that these viruses have a high genetic diversity. 
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Porcine parvovirus is endemic in most areas of the world and one the most important causes 
of reproductive failure in pigs worldwide. Since there is a protective humoral immunity after 
infection, regular vaccination of breeding sows has become a common practice. The 
commercial vaccines represent inactivated virus and were used worldwide after 1980s with 
results considered satisfactory (reviewed by TRUYEN and STRECK 2012). 
The described conservative character of the PPV genome have probably contributed to the 
few monitoring reports of PPV in the 1980s and 1990s. As eukaryotic cells have a cellular 
polymerase complex, with high efficiency in the polymerization of new DNA copies (due to 
their efficient repair unit) and consequent low substitution rate (around 10-9 till 10-10 
substitutions per nucleotide per year), the parvoviruses, that use the host polymerase to 
replication, have their genome considerered to be low mutational, with a substitution rate 
close to the host (DUFFY et al. 2008). On the contrary, RNA viruses, that have their own 
RNA polymerase (without repair unit), have a substitution rate around 10-3 till 10-5 (DRAKE. 
1993). 
More recently, several studies about mutation dynamic showed that additional factors (e.g. 
genomic size, oxidation, deamination and methylation) may drastically affect the viral 
mutation rates (XIA and YUEN 2005; DUFFY et al. 2008). Some DNA viruses (mainly ss 
DNA) evolve swiftly whereas some RNA viruses do not (DUFFY et al. 2008). The first 
estimation of a high substitution rate in ss DNA viruses came from a study reporting the 
emergence of the canine parvovirus 2 (CPV-2) from the feline panleukopenia virus (FPLV). 
For both viruses, a substitution rate of 10-4 was estimated, and, in the main branch where 
CPV-2 emerges, a substitution rate of 7.1 x 10-3 was calculated in the period of time between 
1968 and 1978 (SHACKELTON et al. 2005). After that, high evolution rates were observed 
for other ss DNA as well, including the human parvovirus B19 (SHACKELTON et al. 2006), 
the circovirus sen-V (UMEMURA et al. 2002) and the tomate yellow left curl virus (DUFFY 
and HOLMES 2008). For PPV, in a study amplifying and analyzing no more than 800 base 
pairs, the virus was described as homogeneous, with only few amino acid changes in the 
capsid (SOARES et al. 2003). As PPV, CPV-2 and human parvovirus have a close related 
genomes, a conservative genome only in the PPV seemed to be incongruent. 
This question was addressed in the first manuscript titled “High rate of viral evolution in 
the capsid protein of porcine parvovirus” (Chapter 3). In this study, samples from Austria, 
Brazil, Germany and Switzerland had their genome sequenced (NS1 and VP genes). 
Additionally, the NS1 gene of several older samples (including 143a, 27a, 225b, Challenge, 
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KBSH and others) was sequenced as well. Since there were a lower number of PPV NS1 
sequences available in the DNA databases in comparison to the VP sequences, this 
approach allowed us to analyze both genes with a fair number of sequences. 
As results, a high evolutionary rate (around 10-4 nucleotides substitution per year) was 
observed for PPV capsid genes (complete and partial VP datasets) and a more moderate 
evolution rate was observed for PPV non-structural genes (around 10-5). The capsid gene 
had a lower and higher highest posterior density (HPD) quite similar to the mean rate 
providing strong support to the data, and the root-to-tip analysis indicated that both capsid 
protein datasets have also strong temporal structure. Additionally, the complete and partial 
VP dataset led to similar results, indicating that the partial dataset (shorter sequences, but a 
higher number available at GenBank) is a plausible alternative for phylogenetic studies. 
Despite that, a higher variation in the HPD range and a median temporal regression score 
were observed for the non-structural dataset. Probably, the non-structural proteins of the 
PPV could be more evolutionary stable, resulting in few arguments for the algorithm, and 
consequently, uncertainty in the analysis. 
The differences of the VP and NS1 genes datasets for PPV were higher in comparison to 
similar studies about canine parvovirus and human B19 erythrovirus (SHACKELTON et al. 
2005; SHACKELTON and HOLMES 2006). That a structural gene evolves swiftly compared 
to the non-structural genes suggests that immune selection and tropism shifts could be 
important for the PPV evolution. Moreover, the high substitution rate observed in the VP 
datasets is similar to the substitution rate range observed for ss RNA viruses (DUFFY et al. 
2008), indicating that the PPV is virus capable of faster adaptive evolution. 
The wild phenotypes found in this study displayed the amino acids substitutions mainly 
located in the protein loops. These amino acid sites are further displaced from the center of 
the PPV capsid in comparison with other capsid sites. Differently, the amino acids 
substitutions in the old non-virulent strain NADL2 (isolated in 1976) and the old virulent 
Kresse (isolated in 1985) were mainly located in β-strands, more close to the center of the 
capsid (SIMPSON et al. 2002). The amino acids substitutions on the surface observed in the 
new phenotypes indicate viral changes for the cellular binding and antigenic binding 
activities, indicating that the virus is currently under an adaptation process. 
The phylogenetic trees estimated for the VP1 complete and partial genome contained four 
and seven clades/clusters, respectively. Furthermore, with a molecular clock associated to 
the phylogenetic tree analysis, it could be shown that the main divergences between the 
isolates were introduced in the last 10-30 years for both VPs datasets. As there are few 
samples before 1980, to know if the high substitution rate is a recent event or if it is 
continuous through time was not possible. Recently, it was hypothesized that vaccination 
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could introduce a selective pressure, resulting in new vaccine escape phenotypes. That was 
suggested since antibodies raised with vaccine strains had reduced neutralizing activity 
against new phenotypes (ZEEUW et al. 2007). 
To address this question, population dynamics, an evolutionary branch that studies the 
changes in population size, together with the biological and environmental factors that can 
influence these changes, was used. For viral populations, the accuracy of a vaccine program 
evaluation using population dynamics requires some conditions. First, the dataset should be 
large and embrace enough samples to provide epidemiologic-scale resolution to the 
analysis. Second, the data need to have a temporal structure. Third, all the processes that 
can potentially influence genetic diversity and insert uncertainties in demographic inferences 
should be considered (HALLORAN and HOLMES 2009). For PPV, the sequences available 
in GenBank/EMBL/DDBJ already provide a sufficient temporal fine-grained dataset 
(according the root-to-tip regression in the first and second manuscript). However, the size 
and mainly the geographic distribution of the present dataset are still poor. Currently, the 
publication of PPV DNA sequences is mostly performed by research groups distributed in 
Brazil, China and Germany. Moreover, the continuous development of handling techniques 
and disinfectants could interfere in the analysis as well. 
As alternative, in the second manuscript titled “Population dynamics and in vitro antibody 
pressure of porcine parvovirus indicates decrease of variability” (Chapter 4) an 
additional in vitro approach was performed in cell lines infected with PPV and continually 
submitted to antibody pressure. Cell lines infected with PPV and non-submitted to antibody 
pressure were used as controls. As results, a lower genetic diversity was observed in the 
viruses submitted to the antibody pressure. That was more evident in the strain NADL2 
(antibody homologous and non-virulent strain) submitted to the antibody pressure. The 
difference of this strain cultivated without pressure compared to the strain under pressure 
was of four distinct amino acids. In the Challenge strain (antibody heterologous and virulent 
strain), the strain cultivated without pressure had only one amino acid substitution more. 
Probably, as the antibodies were raised using the NADL2 strain, the consequent antibody 
pressure against the NADL2 was higher. Moreover, the NADL2 strain had higher cellular 
infection and replication capacity in compare to PPV viruses with distinct genetic 
combinations (FERNANDES et al. 2011). Thus, it can be expected that NADL2 strain had 
more generations per passage. It can be suggested that these both factors together 
contributed for the difference observed in the NADL2 strains with antibody pressure and 
without pressure. 
In the in silico model a moderate and continuous reduction in genetic diversity was observed 
after 1985. A main explanation for this phenomenon could be the worldwide use of PPV 
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vaccines in the last 30 years. As a reduction in the genetic diversity is assumed to be strictly 
related to a more difficult or reduced virus transmission (van BALLEGOOIJEN et al. 2009). In 
that, the reduction of genetic diversity caused by vaccination seems to be plausible. 
However, the population dynamic algorithm can be strongly influenced by other non-
evolutionary processes, like sanitary measures, disinfectants and animals separation in 
categories. Additionally, a small number of samples and biased sampling could also interfere 
with the result (HALLORAN and HOLMES 2009). In our study, the sampling size could be 
considered appropriate compared with other viral datasets (FIRTH et al. 2010), but a 
randomly sampled location cannot be reached. 
It was expected to observe a viral escape in those viruses submitted to the antibody pressure 
as well in the sequences retrieved from GenBank. However, it was observed that viruses 
cultivated under antibody pressure were more evolutionary stable compared to the same 
viruses cultivated without this pressure; and for the PPV sequences, a decrease in the 
genetic diversity also was observed matching with the beginning of vaccination. As 
hypothesis, under a selective pressure, most mutations may be deleterious, reducing the 
genetic diversity. It also indicates that, neutral evolution seemed to be more important for the 
emergence of new phenotypes than adaptive evolution. 
For the wild boar populations, a recent analysis indicated that PPV in these animals had 
higher diversity compared with the virus in domestic pigs (CADAR et al. 2012). In a previous 
report (CADAR et al. 2012), the obtained nucleotide substitution rate per year was higher 
than the rate found in the report containing only domestic pigs’ samples (first manuscript of 
this dissertation). As possible explanations there are i. higher viral variability present in wild 
boars; ii. the dissemination of the same virus in herds by mixing animals of different sources; 
iii. the extensive vaccination in domestic swine as factors reducing the PPV variability in 
these populations. 
The amino acids changes in the new phenotypes are mainly located close to the capsid 
surface (first manuscript) with possible importance for the cell-virus interaction or immune 
response. It has already been demonstrated that these phenotypes could have advantages 
compared to some vaccine strains, since antibodies raised against the vaccine strains (strain 
NADL2 and IDT) have a lower neutralization activity against field strain 27a and others 
(ZEEUW et al. 2007; JÓŹWIK et al. 2009). In this context, the dominance of some 
phenotypes in the domestic swine viral population and the consequent decrease of variability 
could be the result of an adaptation. 
The third manuscript of this dissertation described the detection of novel parvoviruses. 
Recently, several asymptomatic or covert virus infections were firstly described (SIJUN et al. 
2011), mainly with the development of the next generation sequencing technologies and 
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numerous bioinformatics methods, as the BLAST program (Basic Local Alignment Search 
Tool) (ALTSCHUL et al. 1990). For parvoviruses, the discovery of the high nucleotide 
substitution rate suggests that, in special occasions, these viruses could undergo rapid 
evolution and generate new genotypes or species. This was observed in the CPV-2, where 
an evolutionary pattern in the FPLV originating the CPV-2 in a short range of years was 
estimated (SHACKELTON et al. 2005). Thereafter, novel parvoviruses were found in several 
species, with a higher number of discover viruses in humans (YOO et al. 1999; NGUYEN et 
al. 2002; FRYER et al. 2006; LAU et al. 2008; LINDNER and MODROW 2008). In pigs, after 
the first description of the virus H-1 (called porcine parvovirus 2) in sera from pigs in 
Myanmar (HIJISAKA et al. 2001), several novel parvoviruses were further identified. For 
these parvoviruses, their biologic properties, epidemiology and veterinary-importance are still 
unknown. 
In the third manuscript, titled “Analysis of porcine parvoviruses in tonsils and hearts 
from healthy pigs revealed high prevalence and genetic diversity in Germany” 
(Chapter 5), tonsils and hearts from 100 pigs were collected in a German slaughterhouse in 
2010 and tested for PPV and the novel parvoviruses [porcine parvovirus 2 (PPV2), porcine 
parvovirus 3 (PPV3, also known as porcine hokovirus) and porcine parvovirus 4 (PPV4)]. As 
result, a high DNA prevalence was observed for PPV and PPV2 in hearts and tonsils, as well 
for PPV3 only in tonsils. 
For PPV, tonsils are considered to be a primary replication site for PPV (TRUYEN and 
STRECK 2012). Since a very high detection rate was observed in this tissue, a secondary 
replication function can be suggested. In hearts, PPV has already been demonstrated in 
piglets presenting a non-suppurative myocarditis (BOLT et al. 1997). For humans, 
prevalence of low DNA level of parvovirus B19 in myocardium is a frequent finding in patients 
with heart disease and also in healthy patients (KUETHE et al. 2009; LOTZE et al. 2010). 
The maintaince of a persistent infection in this tissue with parvovirus B19 is speculated to be 
caused by DNA defective interfering particles or site specific integration in the chromosome. 
Another possible explanation may be that this particular tissue provides a good protective 
place from the immune system (SODERLUND-VENERMO et al. 2002). As this subject is 
speculative, further studies should be performed in order to characterize the persistence 
properties of parvoviruses. 
The tropism for a specific tissue is still unknown for the PPV2, PPV3 and PPV4. However, 
virus DNA presence in hearts and tonsils suggests that both tissues may play a role in the 
viral replication or persistence. Since the heart muscle of swine is designated to human and 
animal food industry, a zoonotic potential of these viruses can be highlighted. For PPV, a 
viral contamination in human products was already observed in the Hyate C porcine factor 
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VIII concentrate designated for hemophilic patients. In this particular case report, no clinical 
implications were found (SOUCIE et al. 2000). However, as PPV can replicate in primary cell 
culture from humans (HALLAUER et al. 1971) a transmission between these hosts appears 
plausible. 
In the PPV amino acid analysis, the sequences 37T-PPV and 80T-PPV were almost identical 
to the virulent 27a strain. This phenotype was first detected in 2001 in Germany 
(ZIMMERMANN et al. 2006) and spread successfully across several countries always related 
to severe diseases (as reported in the first manuscript). In this study, the 27a similar strains 
were detected in non-vaccinated and clinically healthy animals as well. The evidence of this 
phenotype in healthy animals may indicate that apart from the escape potential from the 
current vaccines (ZEEUW et al. 2007), this phenotype could possess higher infection or 
replication efficiency abilities in comparison with concurrent phenotypes. 
The phylogenetic analysis of PPV was calculated with sequences obtained during the last 
ten years (from the DNA databases) together with sequences considered standard (143a, 
225b, 27a, NADL2 and Kresse strains). The sequences 6T-PPV and 55T-PPV were located 
in the cluster D-PPV. The sequences 37T-PPV and 80T-PPV were located in the cluster A-
PPV and were nearly identical to the German 27a strain. In comparison with the phylogenetic 
analysis from the first manuscript (samples retrieved up to September 2010), a new clade (E-
PPV) emerged with moderate posterior probability (0.70) in a period not longer than two 
years. Unfortunately, for the samples grouped in this clade, as well in cluster B, no 
information about their cross-neutralization and virulence properties was available. Further 
studies on these groups can be important to understand veterinary importance of these 
samples. For the PPV2, the phylogenetical analysis reveals that the virus is divided in two 
main clusters. However, more sequences and reports are necessary to come to any 
meaningful conclusion. Finally, for PPV3, two distinct clades are evident as well. Geographic 
relation could be observed, since one clade is formed mostly by samples from China and the 
other clade includes samples from Canada, Germany and Romania. In Germany, five 
(almost) homologous samples from PPV3 have already been observed in wild boars 
(ADLHOCH et al. 2010) and were nearly identical to the sequence T85-PPV3 described in 
this study. For the PPV, PPV2 and PPV3 the phylogeny demonstrated that these viruses 
have a high genetic diversity and no geographic dominance of one group could be observed 
in Germany. 
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In the last years, new PPV phenotypes emerged in Austria, Brazil, Germany and 
Switzerland. These viruses could be observed in abortions and in clinical healthy pigs as 
well. 
 
The PPV DNA was present in hearts and tonsils of fattening pigs with a high detection rate. 
The novel PPV2 was highly prevalent in both tissues and the PPV3 only in tonsils. 
 
The amino acids substitutions of the new PPV phenotypes were located mainly at the capsid 
surface and the outgrowth of a distinct surface profile from the vaccine strains (mainly based 
on the NADL2 strain) can be observed. 
 
The phylogenetic analysis of the PPV, PPV2 and PPV3 demonstrated that these viruses 
have a high genetic diversity and indicates that there is no dominance of a single phenotype 
of PPV, PPV2 or PPV3 in Germany. 
 
The phylogenetic tree associated with a molecular clock for PPV revealed that the new 
clades/cluster emerged for both structural datasets in the last 10-30 years. 
 
A decrease in genetic diversity of PPV was observed in the presence of antibodies in an in 
vitro model or after vaccination in the GenBank content. Since antibodies may have reduced 
neutral selection, vaccine failures and infections in non-vaccinated populations were most 
likely responsible for the emergence of new PPV phenotypes. 
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Porcine parvovirus (PPV) is considered to be one of the most important causes of 
reproductive failure in swine. Fetal death, mummification, stillbirths and delayed return to 
estrus are some of the clinical signs commonly associated with PPV infection in a herd. The 
virus genome is considered to be conservative, with substitution rates near to that of their 
host. However, it has been shown that some parvoviruses exhibit a substitution rate close to 
that commonly determined for RNA viruses. In this scenario, new PPV phenotypes may 
reduce the effectiveness of the currently used vaccines, recommending the continuous 
monitoring of the currently prevalent PPV strains. In addition, a number of novel porcine 
parvoviruses have been described during the last decade, but the importance and 
characteristics of these viruses remain unknown. In the present dissertation, three studies 
were performed to address the PPV genetic variability, to monitor the emergence of new 
PPV strains and the prevalence of novel parvoviruses.  
In the first study, recent PPV field isolates from Austria, Brazil, Germany and Switzerland 
were sequenced and analyzed. These samples, together with sequences retrieved from 
GenBank, were included in three datasets (viral protein complete gene, viral protein partial 
gene and non-structural protein complete gene). For each dataset, the nucleotide 
substitution rate was determined and a molecular clock estimated. The analysis revealed that 
for the new strains, the amino acids substitutions were located mainly in the viral capsid 
loops. Only the capsid protein datasets present the higher suitability for phylogenetic 
analysis. In them, a higher divergence was found, with three well defined clusters. By 
inferring the evolutionary dynamics of the PPV sequences, a nucleotide substitution rate of 
approximately 10-4 substitutions per site per year was found for these datasets. An 
association of the phylogenetic tree with the molecular clock revealed that the main 
divergence of the PPV strains for the viral protein occurred in the last 30 years. 
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In the second study, the population dynamic of PPV isolates from swine herds was analyzed 
using PPV complete protein gene and partial sequences deposited in GenBank. The 
population dynamic of the virus was calculated using a Bayesian approach with a Bayesian 
skyline coalescent model. Additionally, an in vitro model was performed by twenty-one 
consecutives passages of the Challenge strain (a virulent field strain) and NADL2 strain (a 
vaccine strain) in PK15 cell-line supplemented with polyclonal antibodies raised against the 
vaccine strain (negative control was not supplemented). The Bayesian analysis indicated a 
decrease in the population diversity over the years and the predominance of some PPV 
strains. In agreement, the in vitro study revealed that a lower number of mutations appeared 
for both viruses in the presence of anti-PPV antibodies in comparison with the control 
passages without antibodies. 
In the third study, tonsils and hearts from 100 pigs were collected in a German 
slaughterhouse in 2010 and tested for PPV, porcine parvovirus 2 (PPV2), porcine parvovirus 
3 (PPV3) and porcine parvovirus 4 (PPV4). Positive samples of PPV, PPV2 and PPV3 were 
sequenced. PPV was observed in 60/100 hearts and 61/100 tonsils and PPV2 in 55/100 
hearts and 78/100 tonsils. PPV3 and PPV4 could not be detected in the heart samples but 
20/100 and 7/100, respectively, of the tonsils were tested positive. The phylogenetic analysis 
of the PPV, PPV2 and PPV3 sequences revealed that the German samples could be divided 
in at least two clusters or clades for each virus. 
Altogether, it can be concluded that PPV is continuously evolving. Apparently, PPV vaccines 
largely used in the last 30 years probably have reduced the genetic diversity of the virus and 
induced the predominance of strains with distinct capsid profile from the original vaccine-
based strain. Moreover, the high prevalence of the PPV, PPV2 and PPV3 and their genetic 
diversity highlight the importance of the continuous monitoring of these viruses. 
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Die Infektion mit porcinen Parvoviren (PPV) zählt zu den wichtigsten Ursachen von 
Fruchtbarkeitsstörungen beim Schwein. Fetaler Tod, mumifizierte Feten, Totgeburten und 
verzögerter Östrusbeginn sind klinische Symptome, die mit einer PPV-Infektion in einer 
Herde assoziiert sind. Die Nukleotid-Substitutionsraten von PPV und des eukaryontischen 
Wirtes liegen in der gleichen Größenordnung; das PPV-Genom ist entsprechend stark 
konserviert. Kürzlich konnte jedoch für einige Parvoviren eine deutlich höhere Nukleotid-
Substitutionsrate, wie sie bei RNA-Viren anzutreffen ist, gezeigt werden. In diesem 
Zusammenhang könnten neue PPV-Typen auftreten, die die Effektivität der derzeit 
verwendeten Impfstoffe reduzieren könnten. Eine kontinuierliche Überwachung der 
zirkulierenden PPV ist daher geboten. Des Weiteren wurde in den letzten zehn Jahren eine 
Reihe neuartiger, porciner Parvoviren beschrieben, wobei deren klinische Bedeutung 
unbekannt ist. In der vorliegenden Arbeit wurden drei Studien durchgeführt, die die 
genetischen Variabilität von PPV, die Entstehung neuer PPV-Typen und die Prävalenz der 
neuartigen Parvoviren beschreiben.  
In der ersten Studie wurden PPV-Feldisolate aus Brasilien, Deutschland, Österreich und der 
Schweiz sequenziert und analysiert. Diese Proben wurden, zusammen mit Sequenzen aus 
öffentlichen Datenbaken (GenBank), zu drei Datensätzen zusammengefügt [Virusprotein 
(vollständiges Gen), Virusprotein (partielles Gen) und das vollständige Gen des Nicht-
Strukturproteins]. Für jeden Datensatz wurde die Nukleotid-Substitutionsrate bestimmt und 
eine molekulare Uhr berechnet. Die Analysen zeigten, dass die Aminosäuresubstitutionen 
bei den neuartigen PPV-Typen hauptsächlich in den loops des Viruskapsids lokalisiert 
waren. Eingehende phylogenetische Analysen wurden mit den beiden Virusprotein-
Datensätzen (vollständiges und partielles Gen) durchgeführt. In beiden Datensätzen wurde 
im Vergleich mit der Analyse des Nicht-Strukturproteins eine höhere Divergenz mit drei gut 
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definierten Clustern gefunden. Unter Einbeziehung der evolutionären Dynamik der PPV-
Sequenzen, wurde eine Nukleotid-Substitutionsrate von annähernd 10-4 Substitutionen pro 
Position und Jahr in beiden Datensätzen detektiert. Die Verknüpfung der phylogenetischen 
Analyse mit der molekularen Uhr zeigte, dass in den letzten 30 Jahren die 
Hauptunterschiede der PPV-Stämme im Kapsidprotein lokalisiert waren.  
In der zweiten Studie wurde die Populationsdynamik der PPV-Isolate von Schweinen, unter 
Einbeziehung des vollständigen Proteingens und Teilsequenzen aus den öffentlichen 
Datenbaken (GenBank), analysiert. Die Populationsdynamik des Virus wurde durch eine 
Bayesian-Methode mit einem Bayesian skyline coalescent Model berechnet. Zusätzlich 
wurde eine in vitro Untersuchung von 21 aufeinanderfolgenden Passagen durchgeführt. 
Hierzu wurde ein virulenter Feldstamm (Stamm Challenge) sowie ein Impfstamm (Stamm 
NADL2) in einer PK-15 Zelllinie vermehrt. Das Zellkulturmedium war mit polyklonalen 
Antikörpern gegen den Impfstamm supplementiert (Negativkontrolle ohne Antikörper-
Zusatz). Die Bayesian-Analyse zeigte eine Abnahme der Populationsdiversität mit der Zeit 
sowie die Dominanz einiger PPV-Stämme. Die in vitro Studie ergab, dass bei beidem Viren 
die Anwesenheit von anti-PPV Antikörpern, im Vergleich zu der Kontrollpassage ohne 
Antikörper, eine geringeren Anzahl von Mutationen bewirkt. 
In der dritten Studie wurden im Jahr 2010 Tonsillen und Herzen von 100 Schweinen in einem 
deutschen Schlachthof gesammelt. Die Organe wurden auf PPV, porcines Parvovirus 2 
(PPV2), porcines Parvovirus 3 (PPV3) und porcines Parvovirus 4 (PPV4) untersucht. 
Positive Proben von PPV, PPV2 und PPV3 wurden im Anschluss sequenziert. PPV wurde in 
60 Herzen sowie 61 Tonsillen, PPV2 in 55 Herzen und 78 Tonsillen nachgewiesen. PPV3 
und PPV4 konnten in keiner Herzprobe detektiert werden, aber in 20 (PPV3) bzw. sieben 
(PPV4) Tonsillen. Die phylogenetischen Analysen der PPV, PPV2 und PPV3 Sequenzen 
verdeutlichten, dass die Isolate für jedes Virus mindestens zwei Cluster oder Clades bilden.  
Insgesamt konnte eine kontinuierliche Evolution von PPV festgestellt werden. In den letzten 
30 Jahren führte möglicherweise die starke Nutzung von PPV-Impfstoffen zu einer Abnahme 
der genetischen Diversität des Virus. Die neuen Typen weisen innerhalb der PPV-Population 
eine deutliche Ausbreitungstendenz auf. Darüber hinaus unterstreicht die hohe Prävalenz 
von PPV, PPV2 und PPV3 und ihre genetische Diversität die Bedeutung der kontinuierlichen 
Überwachung dieser Viren.  
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SUPPLEMENTARY TABLE: Primers used in the PPV genome amplification 
Primer pairs Sequence (5´ - 3´) Location Target 
P1-NS1 TGC TTC AGA CTG CAC TTC G 232-250 NS1 
 
TCY CTT AAT TTT ATT CTT TCA ACT GG 793-818 
 
P2-NS1 AAA TGG TTC AGA AAA CAA TTA AAC AA 721-746 NS1 
 
GTC ATA TGC TGT TTT TGT TCT TGC 1291-1314 
 
P3-NS1 GCT CAA ACC GGA GGA GAA AA 1231-1250 NS1 
 
GTT TAA CAT TCT GTC TCT TAT TGG TTG 1798-1824 
 
P4-NS1 GGA AGC AAA CAA ATT GAA CCA 1702-1722 NS1 
 
CAC CAC CCC CTT AAA ACT ACC 2320-2340 
 
PPV I ATG CAT CAT TGG GGA AAT GT 1913-1932 VP1 
 
TTC GTC GTG TTC TTT TGC TG 2443-2462 
 
PPV II CAG CAA AAG AAC ACG ACG AA 2443-2462 VP1/2 
 
CCC CAT GCG TTA GCA TCT AT 3117-3136 
 
PPV III GGG AGG GCT TGG TTA GAA TC 2950-2969 VP1/2 
 
TCC TAC CTG AGC TGG CCT AA 3772-3791 
 
PPV IV TTA GGC CAG CTC AGG TAG GA 3772-3791 VP1/2 
 
TTT CTG CTG TTG TTG TGT GTT G 4417-4437 
 
PPV V TCA AAC TTT TGG TGG AAA GGA 4341-4361 VP1/2 
 
GGG CGA CCA ACT AAC TCA AA 4899-4918 
 
D5 GGC CAC TAA TAT GTG CTT GGT T 1854-1875 VP1/2 
 
TTG GAG CAG GTC TTT TTC CTG G 2697-2718 
 
D7 CCA TGG TTA CCT ACA AAA CCA ACT C 3378-3401 VP1/2 
 
ACA GGT GCA GTA TTG TTT AGT GCT GTT 4135-4159 
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SUPPLEMENTARY TABLE: Primers used in the PPV VP1 gene and in the PPV2, PPV3 
genome amplification 
Primer pairs Sequence (5´ - 3´) Location 
PPV I ATGCATCATTGGGGAAATGT 1913-1932 
 
TTCGTCGTGTTCTTTTGCTG 2443-2462 
PPV II CAGCAAAAGAACACGACGAA 2443-2462 
 
CCCCATGCGTTAGCATCTAT 3117-3136 
PPV III GGGAGGGCTTGGTTAGAATC 2950-2969 
 
TCCTACCTGAGCTGGCCTAA 3772-3791 
PPV IV TTAGGCCAGCTCAGGTAGGA 3772-3791 
 
TTTCTGCTGTTGTTGTGTGTTG 4417-4437 
PPV V TCAAACTTTTGGTGGAAAGGA 4341-4361 
 
GGGCGACCAACTAACTCAAA 4899-4918 
PPV D5  GGCCACTAATATGTGCTTGGTT 1854-1875 
 
TTGGAGCAGGTCTTTTTCCTGG 2697-2718 
PPV D7  CCATGGTTACCTACAAAACCAACTC 3378-3401 
 
ACAGGTGCAGTATTGTTTAGTGCTGTT 4135-4159 
PPV2 P1 CGGACCGGAAGTCGCCGAATG 16-36 
 
TGATCGCCTTCCCACCAGCG 675-694 
PPV2 P2 CGGCACAAAGGCCCGAGGG 555-573 
 
AGCGGGACCGAACAGCCAGA 1234-1253 
PPV2 P2-newa GCGGCTCTTGAGAGGCCCGG 1558-1577 
PPV2 P3 CGCAGGGAACTCGTAGCAGGGA 1053-1074 
 
TGGAGCTACCGGTGCTACGGC 1725-1745 
PPV2 P4 GCTCCGAGACCTCCCCAGCT 1643-1662 
 
CTCTCCGCCCGCCAGAGTTG 2355-2374 
PPV2 P5 GGTAAGCGGCCATGAGCGCT 2249-2268 
 
TCTCTTCAGGTGCCGGCCGA 2925-2944 
PPV2 P6 CTGGGGTACCTGGGCAGAGCTT 2787-2808 
 
AATGCGCACAATCCCACCCCC 3589-3609 
PPV2 P6-newa GGTGGTTTCTGGGATAAAATTAAGG 2467-2491 
 
GATGAGCTCGTCGTACCGCTCATCG 3183-3207 
PPV2 P7 CCGCCCGCCCAAAAACCAAGA 3499-3519 
 
AAAGAACTCCGTGTCCGCGCT 4210-4230 
PPV2 P8 GGTACAACCCTCCCCAATACGCCT 4118-4141 
 
CAGAGGACCGAGCAAAGGCCAT 4675-4696 
PPV2 P8-newa CCGAGAGCATCCGGGCATTGGC 3676-3697 
 
AAACCCCTGAGGAAATATGTCC 4443-4464 
PPV2 P9 TCGCCAGGGGGAGGTAGAGAGAA 4629-4651 
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GGGTCGCCGGACTCCGTGTAA 5238-5258 
PPV2 P10 CGAGCGCCCCCTCTGTTACG 4941-4960 
 
AGGTCGGACCGGAAGTCGCC 5570-5589 
PPV3 P1 GTTCCGGTTGCGTATTTCC 2-20b 
 
TGTTAGTCCAAGCATACCAGACA 627-649 
PPV3 P2 TGTATCAGTGCGACCTGAC 566-584 
 
TGGCAGTCATTGAATGGAAA 1219-1238 
PPV3 P3 TCTTATGGCTGCGTGAATTG 1186-1205 
 
AGACACGTCCGTGGACTCAT 1748-1767 
PPV3 P4 GGCAGCCGATGAGTCCAC 1740-1757 
 
CACATGGGAGAAGGCTTGTT 2342-2361 
PPV3 P5 CGAGCCATCATCATGGAGTA 2271-2290 
 
ATCGTACCGTTCATCGTGGT 2933-2952 
PPV3 P6 GCTAAGGGACCAGTGGATGA 2902-2921 
 
ATGGAGTCCGCATACCCATA 3483-3502 
PPV3 P7 GGGGCACTCATTTCTCTGAT 3359-3378 
 
CTGGCCTTTTCCACTTAGGA 4053-4072 
PPV3 P8 GCGATCATGACAGGGGTAGA 4021-4040 
 
AGCCACCCAGTAGGGGATAC 4626-4645 
PPV3 P9 CCTATTCCCTGCTGCTGTGT 4530-4549 
 
TTGTTGCATCAGCAATGAATC 5006-5026b 
aAdditional primers needed for some sequences 
bNumber according the PPV3 strain HK3 (EU200673). 
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SUPPLEMENTARY TABLE: Samples of heart (H) and tonsil (T) submitted to cell 
inoculation and their respective PCR results for PPV, PPV2, PPV3, PPV4 and PBoV. 
Samples PPV PPV2 PPV3 PPV4 PBoV 
8H - + - - - 
14H + + - - - 
26H + - - - - 
41H - + - - - 
43H + + - - - 
44H - + - - - 
68H + + - - - 
92H - + - - - 
9T - + - - - 
37T + + + - - 
40T + + + - - 
43T - + - - - 
62T - + + - - 
65T - - + - - 
86T + + + + - 
90T - + + - - 
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